Medizinische Universität Graz - Research portal
Fickert Peter |
Presentations at scientific and public conferences
Fickert, P
Gastroenterologische Fallbeispiele: Was habe ich heute schon gelernt?
FOMF - Innere Medizin Update Refresher Wien 11.24; NOV 26-30, 2024; Vienna, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
Encephalopathie vor und nach Lebertransplantation
Lebertransplantationskurs 2024; FEB 1-2, 2024; Innsbruck, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
State-of-the-Art Lecture „Cholestatische Hepatopathien“.
Seminarband der XX. Gastroenterologie-Seminarwoche Titisee. 2024; -XX. Gastroenterologie-Seminarwoche Titisee – FALK Foundation; FEB 24-28, 2024; Titisee, GERMANY.
[Keynote lecture]
Fickert, P
Digestiv.
Frühling der Hepatologie 2024; MAR 16, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch UPDATE HEPATOLOGIE 2024. 2024; -Hepato Update 2024 ; APR 26-27, 2024; Berlin, GERMANY. (ISBN: 978-3-98769-283-3 )
[Oral Communication]
Fickert, P
Herausforderungen bei der Behandlung von primärer biliärer Cholangis (PBC): Ein Blick auf die österreichische Realität.
IPSEN Advisoryboard PBC - Elafibranor; MAY 7, 2024; Vienna, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
Was gibt es Neues zu den immunologischen Leberkrankheiten?
FOMF - Allgemeinmedizin Update Refresher 06.24; JUN 11-14, 2024; Vienna, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
AI in der Gastroenterologie
ÖGIM - 55. Jahrestagung; SEP 18-20, 2024; Salzburg, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
Klinisches Management cholestatischer Lebererkrankungen.
Update Gastroenterologie-Stoffwechsel; NOV 14-16, 2024; Innsbruck, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
Therapie bei Fettleber.
FOMF - Innere Medizin Update Refresher Wien 11.24; NOV 26-30, 2024; Vienna, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
Was gibt es Neues in der Diagnostik und Therapie immunologischer Leberkrankheiten?
FOMF - Innere Medizin Update Refresher Wien 11.24; NOV 26-30, 2024; Vienna, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
Was wir aus Tiermodellen über Cholestase lernen können
Helmut Denk Symposium; MAR 15, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
Knifflige Probleme beim Gallensteinleiden.
FOMF - Web Up Expertenforum Innere Medizin ; APR 11, 2024; Vienna, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
Was sollen wir ab jetzt tun? Wie aus Gesundheitsarbeiter*innen wieder Ärzt*innen werden.
Science on Top; JUN 21-23, 2024; Wagrain, AUSTRIA. 2024.
[Keynote lecture]
Fickert, P
Update Indikationen zur LTx.
6. Grazer Transplantationssymposium; MAR 8, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
Serumgallensäurendiagnostik: Wie, Wen, Wann untersuchen?
Symposium Labormedizin; MAY 7-8, 2024; Seggauberg bei Graz, AUSTRIA. 2024.
[Oral Communication]
Fickert, P
Hepatologie praktisch: Check-up für die Leber.
Ärztetage Grado 2024; MAY 26 – JUN 1, 2024; Grado, ITALY. 2024.
[Oral Communication]
Fickert, P
Hepatologie praktisch: Therapie von Lebererkrankungen und deren Komplikationen.
Ärztetage Grado 2024; MAY 26 – JUN 1, 2024; Grado, ITALY. 2024.
[Oral Communication]
Fickert, P
Virale Hepatitiden 2024 - Who cares?
FOMF - Allgemeinmedizin Update Refresher 06.24; JUN 11-14, 2024; Vienna, AUSTRIA. 2024.
[Keynote lecture]
Gulden, L; Katz,L; Fickert, P; Panzitt, K; Wagner, M
Role of the autophagy inhibitor rubicon in a psc mouse model.
IPSCGW Young Investigator Workshop; Dec 16-17. 2024; Birmingham. 2024.
[Oral Communication]
Egger, M; Horvath, A; Prüller, F; Fickert, P; Prattes, J; Krause, R; Hoenigl, M; Stadlbauer, V
Fungal translocation measured by serum 1,3-Beta-D-glucan is associated with severity and outcome of liver cirrhosis - a pilot study
. 2023; ( ): - .-The 33rd European Congress of Clinical Microbiology & Infectious Diseases; APR 15-18; 2023; Copenhagen, DENMARK. (ISBN: )
[Poster]
FullText
Fickert, P
Häufige gastroenterologische und hepatologische Erkrankungen - Praktische Fallbeispiele
Jungärzte Update Refresher Wien 02.23; FEB 28 - MAR 02, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Das Management chronischer Lebererkrankungen 2023
Innere Medizin Update Refresher Wien 11.23; Nov 28 - DEC 2, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Chronisch entzündliche Darmkrankheiten - Was ist relevant in der hausärztlichen Betreuung?
Allgemeinmedizin Update Refresher Wien 11.23; NOV 8-11, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Neues zur Therapie der akuten Divertikulitis
Innere Medizin Update Refresher Graz 10.23; OCT 3-7, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Klug entscheiden in der Gastroenterologie - Fallbesprechungen
Allgemeinmedizin Update Refresher Salzburg 09.23; SEP 27-30, 2023; Salzburg, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Refluxbeschwerden und Dysphagie
Allgemeinmedizin Update Refresher Salzburg 09.23; SEP 27-30, 2023; Salzburg, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Gastroenterologie und Hepatologie 2030
Summerschool der ÖGGH; SEP 10-13, 2023; Attersee am Attersee, AUSTRIA. 2023.
[Oral Communication]
Fickert, P
Vorsorge und Früherkennung gastroenterologischer Tumore
Innere Medizin Update Refresher Wien 06.23; JUN 20-24, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Nahrungsmittelunverträglichkeiten und -allergien - Erkennen und behandeln
Jungärzte Update Refresher Wien 02.23; FEB 28 - MAR 02, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Vorsorge und Früherkennung gastroenterologischer Tumore
Innere Medizin Update Refresher Graz 10.23; OCT 3-7, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Immune-mediated and cholestatic diseases
Abstract Book of EASL Congress 2023. 2023; 78, Supplement 1: S1-S1314.-EASL ILC 2023; JUN 21-24, 2023; Vienna, AUSTRIA.
[Oral Communication]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch UPDATE HEPATOLOGIE 2023. 2023; -Hepato Update 2023; MAY 12-13, 2023; Frankfurt, GERMANY. (ISBN: 978-3-98769-168-3 )
[Keynote lecture]
Fickert, P
Acute on Chronic Liver Failure and Futility
Lebertransplantationskurs 2023; MAR 23-24, 2023; Innsbruck, AUSTRIA. 2023.
[Oral Communication]
Fickert, P
Diarrhoe – Diagnostik und Therapie
Innere Medizin Update Refresher Graz 10.23; OCT 3-7, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Reizmagen und Reizdarm - Aktuelles Management
Allgemeinmedizin Update Refresher Graz 01.23; JAN 25-28, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
"Volkskrankheit" Fettleber - Diagnostik und Therapie
Allgemeinmedizin Update Refresher Graz 01.23; JAN 25-28, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Chronisch entzündliche Darmkrankheiten - Was ist relevant in der hausärztlichen Betreuung?
Allgemeinmedizin Update Refresher Graz 01.23; JAN 25-28, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Virale Hepatitiden
Innere Medizin Update Refresher Wien 06.23; JUN 20-24, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Leber - Was wir wissen wollten!
FALK Kickoff Tagung; JAN 17, 2024; Leibnitz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Nichtalkoholische Steatohepatitis (NASH)
Innere Medizin Compact - Leber; Nov 20, 2023; Vienna, AUSTRIA. 2023.
[Oral Communication]
Fickert, P
"Volkskrankheit" Fettleber - Diagnostik und Therapie
Allgemeinmedizin Update Refresher Wien 11.23; NOV 8-11, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Virale Hepatitiden
Innere Medizin Update Refresher Graz 10.23; OCT 3-7, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Häufige Lebererkrankungen - Diagnostik und Therapie
Allgemeinmedizin Update Refresher Salzburg 09.23; SEP 27-30, 2023; Salzburg, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Neue diagnostische Methoden in der Endoskopie und der Funktionsdiagnostik
Innere Medizin Update Refresher Wien 11.23; Nov 28 - DEC 2, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Nahrungsmittelunverträglichkeiten - Gluten, Laktose, Fruktose, Sorbit
Innere Medizin Update Refresher Wien 11.23; Nov 28 - DEC 2, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Reizmagen und Reizdarm - Aktuelles Management
Allgemeinmedizin Update Refresher Wien 11.23; NOV 8-11, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Erhöhte Leberwerte und fokale Leberläsionen im Ultraschall – Wie geht es weiter?
Innere Medizin Update Refresher Graz 10.23; OCT 3-7, 2023; Graz, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Erhöhte Leberwerte und fokale Leberläsionen im Ultraschall - Wie geht es weiter?
Innere Medizin Update Refresher Wien 06.23; JUN 20-24, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Diarrhoe - Diagnostik und Therapie
Innere Medizin Update Refresher Wien 06.23; JUN 20-24, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Fickert, P
Neues zur Therapie der akuten Divertikulitis
Innere Medizin Update Refresher Wien 06.23; JUN 20-24, 2023; Vienna, AUSTRIA. 2023.
[Keynote lecture]
Panzitt, K; Jungwirth, E; Madreiter-Sokolowski, C; Madl, T; Trauner, M; Fickert, P; Moore, DD; Thallinger, GG; Marschall, HU; Wagner, M;
FXR signaling is shifted in humans with obesity and adapts hepatic mitochondrial function to increased substrate oxidation
Experimental Hepatology Days, Falk Symposium 233; MAY 18-20, 2023; Zurich, SWITZERLAND. 2023.
[Oral Communication]
Trauner, M; Fickert, P; Trivedi, P; Denk, G; Färkkilä, M; Dill, M; Villadsen, GE; Berg, C; Jorgensen, KK; Vetter, M; Müller, T; Müllhaupt, B; Schramm, C; Strassburg, C; Bantel, H; Böttler, T; Beuers, U; Louvet, A; Halilbasic, E; Stiess, M; Proels, M; Manns, MP
Norucholic acid for the treatment of primary sclerosing cholangitis: baseline data from a phase III trial
J HEPATOL. Abstracts. 2023; 78(S1):S403-S403.-EASL Congress 2023; JUN 21-24, 2023; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Vargek, M; Reynders, M; Sommer, J; Silbert-Wagner, D; Fickert, P; Moustafa, T;
FIBROBLAST GROWTH FACTORS 15 AND 21 ARE BOTH REQUIRED TO MAINTAIN hepatic and adipose METABOLISM
European lipoprotein club: report of the 46th ELC annual conference. Tutzing, 11–14 September 2023; Atherosclerosis 2003. 2023; -46th Annual Scientific Meeting of the European Lipoprotein Club; September 11-14, 2023; Tutzing, Germany.
[Oral Communication]
FullText
Balazs, I; Racedo, S; Fickert, P; Stadlbauer, V
Comparative analysis between different types of autoantibodies and their effects on NETs formation
Zeitschrift für Gastroenterologie. 2022; 60(08):e688-e688.-55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEP 7-9, 2022; Vienna, AUSTRIA.
[Poster]
FullText
Fandler-Höfler, S; Kneihsl, M; Stauber, RE; Mangge, H; Wünsch, G; Haidegger, M; Fickert, P; Enzinger, C; Gattringer, T
LIVER FIBROSIS IS RELATED TO ATRIAL FIBRILLATION AND OUTCOME IN ACUTE ISCHEMIC STROKE
European Stroke Journal, ESOC 2022 Abstract Book. 2022; -8th European Stroke Organisation Conference; May 4-6, 2022; Lyon, France.
[Oral Communication]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch UPDATE HEPATOLOGIE 2022. 2022; -Hepato Update 2022; MAY 6-7, 2022; Berlin, GERMANY.
[Keynote lecture]
Fickert, P
Das europäische Ausbildungsmodell
Summerschool der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; SEP 3-6, 2022; Attersee, AUSTRIA. 2022.
[Keynote lecture]
Fickert, P
Gallenwegs- und Pankreaserkrankungen
Innere Medizin Update Refresher Wien 11.22; NOV 29 - DEC 3, 2022; Vienna, AUSTRIA. 2022.
[Oral Communication]
Fickert, P
Chronisch entzündliche Darmerkrankung
Allgemeinmedizin Upodate Refresher Salzburg 09.22; SEP 28 - OCT 1, 2022; Salzburg, AUSTRIA. 2022.
[Keynote lecture]
Fickert, P
International Mobility: To Leave or not to Leave, that is the Question
The International Liver Congress™ 2022 Congress Review. 2022; -EASL International Liver Congress 2022; JUN 22-26, 2022; London, UNITED KINGDOM.
[Oral Communication]
Fickert, P
Klinisches Management von cholestatischen Lebererkrankungen
20 Jahre Update Gastroenterologie-Stoffwechsel; NOV 10-12, 2022; Innsbruck, AUSTRIA. 2022.
[Oral Communication]
Fickert, P
Gallenwegserkrankungen
Allgemeinmedizin Update Refresher Salzburg 09.22; SEP 28 - OCT 1, 2022; Salzburg, AUSTRIA. 2022.
[Keynote lecture]
Fickert, P
Eosinophile Ösophagitis
Fortbildung im Bezirk "Eosinophile Ösophagitis"; SEP 27, 2022; Judendorf-Straßengel, AUSTRIA. 2022.
[Keynote lecture]
Fickert, P
Gastroenterologie/Hepatologie 2030 –
Worauf müssen wir uns vorbereiten?
55. JAHRESTAGUNG & 32. FORTBILDUNGSKURS der ÖGGH; SEP 7-9, 2022; Vienna, AUSTRIA. 2022.
[Keynote lecture]
Hartl, L; Tatscher, E; Weiß, M; Balcar, L; Strassl, R; Jachs, M; Mandorfer, M; Soliman, T; Stadlbauer, V; Schemmer, P; Berlakovich, G; Tilg, H; Schneeberger, S; Trauner, M; Fickert, P; Reiberger, T; Graziadei, I
Impact of COVID-19 on liver transplantation in Austria.
Abstracts 55. Jahrestagung & 32. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). 2022; -55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEPT 7-9, 2022; Vienna, AUSTRIA.
[Poster]
Stelzl, A; Fickert, P
Was bedeutet klinische Hepatologie?
Summerschool der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; SEP 3-6, 2022; Attersee, AUSTRIA. 2022.
[Oral Communication]
Fandler-Hofler, S; Stauber, R; Kneihsl, M; Wunsch, G; Haidegger, M; Poltrum, B; Pichler, A; Deutschmann, H; Enzinger, C; Fickert, P; Gattringer, T
Liver fibrosis is associated with atrial fibrillation and worse outcome in large vessel occlusion stroke
EUR J NEUROL. 2021; 28: 151-151.-7th Congress of the European Academy of Neurology; June 19-22, 2021; Vienna, Austria.
[Oral Communication]
Web of Science
Fandler-Höfler, S; Stauber, R; Kneihsl, M; Wünsch, G; Haidegger, M; Poltrum, B; Pichler, A; Deutschmann, H; Enzinger, C; Fickert, P; Gattringer, T
SUBCLINICAL LIVER FIBROSIS RELATES TO
POOR PROGNOSIS IN PATIENTS TREATED
WITH MECHANICAL THROMBECTOMY
European Stroke Journal. 2021; 6(1_supp):-European Stroke Organisation Conference; SEPT 1-3, 2021; Helsinki, Finland.
[Onlinepräsentation]
FullText
Fickert, P
Rationelle Abklärung - Bauchschmerz
Innere Medizin Update Refresher Wien 06.21; JUN 17, 2021; Vienna, AUSTRIA. 2021.
[Keynote lecture]
Fickert, P
"Volkskrankheit" Fettleber - Diagnostik und Therapie
Allgemeinmedizin Update Refresher Graz 01.23; JAN 25-28, 2023; Graz, AUSTRIA. 2021.
[Keynote lecture]
Fickert, P
Moderne Diagnostik bei unklaren Ober- und Unterbauchschmerzen
Allgemeinmedizin Update Refresher Graz 01.21; JAN 28, 2021; Graz, AUSTRIA. 2021.
[Keynote lecture]
Fickert, P
Der Mensch im Mittelpunkt
UNIVERSUM INNERE MEDIZIN. 2021; UIM 07|2021: -52. Jahrestagung ÖGIM; SEP 23-24, 2021; Salzburg, AUSTRIA.
Fickert, P
Moderne Diagnostik bei unklaren Ober- und Unterbauchschmerzen
Allgemeinmedizin Update Refresher; JUN 16-19, 2021; Vienna, AUSTRIA. 2021.
[Oral Communication]
Fickert, P
Dekompensierte Lebererkrankung - Wann zur Transplantation?
liVelineGastroHepatology - ÖGGH goes virtual; MAR 9, 2021; Vienna, AUSTRIA. 2021.
[Keynote lecture]
Fickert, P
Akut intermittierende Porphyrie
Interdisziplinäres Advisory Board Austria; OCT 20, 2021; Vienna, AUSTRIA. 2021.
[Keynote lecture]
Fickert, P
Leberzirrhose und ihre Komplikationen
Innere Medizin Compact LEBER; SEP 27, 2021; Vienna, AUSTRIA. 2021.
[Keynote lecture]
Fickert, P
Therapien bei cholestatischen Hepatopathien
Wrap-Up Hepatologie AASLD | EASL 2020; JAN 9, 2021; Vienna, AUSTRIA. 2021.
[Onlinepräsentation]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch UPDATE HEPATOLOGIE 2021. 2021; 5-1-5-51.-Hepato Update 2021; JUN 11-12, 2021; Mainz, GERMANY. (ISBN: 978-3-86302-645-6 )
[Onlinepräsentation]
Fickert, P; Strassburg, C
Sickest patient first?
Austrotransplant 2021; OCT 20-22, 2021; Spielberg, AUSTRIA. 2021.
[Oral Communication]
Kohlmaier, B; Gunther, N; Benesch, M; Fickert, P; Lackner, H; Lagler, H; Liegl-Atzwanger, B; Stadlbauer, V; Strenger, V; Stroedter, L; Sorantin, E; Till, H; Zenz, W; Hauer, A.
Leberzyste und pulmonale Rundherde - Zystische Echinokokkose und andere Bösartigkeiten.
Abstractband Monatsschrift Kinderheilkunde. 2021; 169, Suppl. 2: S60--59. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; SEP 30 - OCT 2, 2021; Salzburg, AUSTRIA.
[Poster]
Zaufel, A; Sommer, J; Silbert-Wagner, D; Racedo, S; Fauler, G; Efeyan, A; Sun, W; Wolfrum, C; Fickert, P; Moustafa, T
The lysosomal LAMTOR/Ragulator complex regulates hepatocellular metabolism and liver cell fate.
https://www.lipidmeeting.de/. 2021; -XXII LIPID MEETING ; Dez 9-11,2021; Leipzig, Deutschland.
[Poster]
Fickert P
Moderne Diagnostik bei unklaren Ober- und Unterbauchschmerzen.
Allgemeinmedizin Update Refresher; Nov 11-14, 2020; Vienna, AUSTRIA. 2020.
[Oral Communication]
Fickert P
Autoimmune Leber- und Gallenwegserkrankungen.
Hepato Update 2020 – Handbuch. 2020; -Hepato Update 2020; May 15-16, 2020; Berlin, GERMANY. (ISBN: ISBN 978-3-86302-869 )
[Keynote lecture]
Fickert P
Die akute hepatische Porphyrie in Österreich: Überblick und Update 2020.
Advisory Board Meeting "Givosiran - eine neue Therapieoption in der Behandlung der Akuten Hepatischen Porphyrie"; Mar 5, 2020; Vienna, AUSTRIA. 2020.
[Poster]
Fickert P
Der weite Gallen- oder Pankreasgang - Was ist überhaupt abklärungsbedürftig?
Endo Linz 2020; Jan 30-31, 2020; Linz, AUSTRIA. 2020.
[Keynote lecture]
Fickert P
Lenvatinib beim hepatozellulären Karzinom.
Strategic Advisory Board ; Jan 24, 2020; Vienna, AUSTRIA. 2020.
[Keynote lecture]
Fickert P
Hepatopulmonales Syndrom.
Nephrologie Update 2.0; Nov 13-14, 2020; Graz, AUSTRIA. 2020.
[Oral Communication]
Fickert P
Filgotinib in der Behandlung der UC.
Gilead Advisory Board Meeting; Dec 17, 2020; Vienna, AUSTRIA. 2020.
[Keynote lecture]
Fickert P
Notfälle in der Gastroenterologie.
Innere Medizin Update Refresher; Dec 3, 2020; Vienna, AUSTRIA. 2020.
[Oral Communication]
Fickert P; Trauner M
Pankreas und Cholangiocelluläres Karzinom.
ÖGGH Onko-Wintersymposium; Jan 25, 2020; Vienna, AUSTRIA. 2020.
[Keynote lecture]
Fürschuß, L; Rainer, F; Effenberger, M; Niederreiter, M; Portugaller, R; Fickert, P; Stadlbauer, V
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt (TIPS).
Digital ILC 2020 Abstract book. 2020; -The Digital International Liver Congress 2020; AUG 27-29, 2020; London, UK.
[Poster]
Fürschuß, L; Rainer, F; Effenberger, M; Niederreiter, M; Portugaller, RH; Fickert, P; Stadlbauer, V
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency.
Zeitschrift für Gastroenterologie / German Journal of Gastroenterology 2020. 2020; (58):e102-e102.-53. ÖGGH Jahrestagung 2020; JUN 18-19, 2020; Vienna, AUSTRIA.
[Poster]
Furschuss, L; Rainer, F; Effenberger, M; Niederreiter, M; Portugaller, RH; Fickert, P; Stadlbauer, V
The modified TIPS-Score (MOTS) improves the Assessment of the Mortality Risk after transjugular intrahepatic portosystemic Shunt (TIPS) and thus the Patient Selection.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):76-77.London, online.
[Poster]
Web of Science
Konrad J; Schlager H; Rainer F; Spindelböck W; Högenauer C;
Fickert P; Eherer A
Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte.
Zeitschrift für Gastroenterologie / German Journal of Gastroenterology 2020; 58: e72. 2020; -53. Jahrestagung der ÖGGH; JUN 18-19, 2020; Vienna, AUSTRIA.
[Poster]
FullText
Fickert, P
Nicht-alkoholische Fettleber (NAFL)
ÖGIM Innere Medizin Compact 2019 / Leber; SEP 16, 2019; Wien, AUSTRIA. 2019.
[Keynote lecture]
Fickert, P
Update Leber mit besonderem Augenmerk auf HCC - Neue Therapieoptionen
EISAI Vortragsreihe "Hepatozelluläres Karzinom"; OCT 29, 2019; Villach, AUSTRIA. 2019.
[Keynote lecture]
Fickert, P
Update Leber mit besonderem Augenmerk auf HCC
EISAI Vortragsreihe "Hepatozelluläres Karzinom"; OCT 30, 2019; Oberwart, AUSTRIA. 2019.
[Keynote lecture]
Fickert, P
Update Leber mit besonderem Augenmerk auf Transplant und medizinische Therapien - richtiges Timing entscheidet
Vortragsreihe "Hepatozelluläres Karzinom"; NOV 12, 2019; Graz, AUSTRIA. 2019.
[Keynote lecture]
Fickert, P
HCV positive organs - should they be accepted in the area of successful HCV therapy and is it worth the effort?
Eurotransplant Annual Meeting 2019; OCT 10-11, 2019; Leiden, THE NETHERLANDS. 2019.
[Oral Communication]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch Hepato Update 2019. 2019; -Hepato Update 2019; MAY 24-25, 2019; Berlin, GERMANY. (ISBN: ISBN 978-3-86302-730 )
[Keynote lecture]
Fickert, P
Management der primär sklerosierenden Cholangitis (PSC) - Standard heute und morgen
FALK 25. Sympoisum "Aktuelle Hepatologie"; MAY 4, 2019; Wiesbaden, GERMANY. 2019.
[Keynote lecture]
Fickert, P
Medizinstudium - quo vadis?
Sommergespräch; Jun 12, 2019; Linz, AUSTRIA. 2019.
[Keynote lecture]
Fickert, P
Update zu cholestatischen Lebererkrankungen
Symposium SANCT GALLEN 2019 Gastroenterology / Hepatology ; DEC 5, 2019; St. Gallen, SWITZERLAND. 2019.
[Keynote lecture]
Fickert, P
PSC und PSC-IBD: ist das die dritte Entität der CED?
Österreichisches Crohn Colitis Symposium 2019; SEP 27-28, 2019; Bad Ischl, AUSTRIA. 2019.
[Oral Communication]
Fickert, P
Malabsorption und Reizdarm
50. Jahrestagung ÖGIM 2019; SEP 19-21, 2019; Salzburg, AUSTRIA. 2019.
[Oral Communication]
Fickert, P
Gallensteinleiden: Gastroenterologie vor Chirurgie?
52. Jahrestagung & 30. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; Jun 13-15, 2019; Innsbruck, AUSTRIA. 2019.
[Oral Communication]
Fickert, P
Ätiologie & kausale Therapie des ALF.
Lebertransplantationskurs; JAN 31 - FEB 1, 2019; Innsbruck, AUSTRIA. 2019.
[Oral Communication]
Horvath, A; Durdevic, M; Leber, B; di Vora, K; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V
Changes in the intestinal microbiome during probiotic intervention in cirrhosis
J HEPATOL. 2019; 70: E648-E648.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA.
Doi: 10.1016/S0618-8278(19)31290-3
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelböck, W; Baumann-Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V:
The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis
Z Gastroenterol 2019; 57(05): e158
DOI: 10.1055/s-0039-1691924. 2019; -Jahrestagung der ÖGGH; JUN 13-15, 2019; Innsbruck, Austria.
[Poster]
Kniepeiss, D; Janout, S; Schrem, H; Mathe, Z; Bachmaier, G; Lackner, C; Fickert, P; Toller, W; Muller, H; Schemmer, P
EXCELLENT OUTCOME QUALITY IS NOT DEPENDENT ON A HIGH CASELOAD IN LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 30-30.-28. Jahrestagung der Deutschen Transplantationsgesellschaft, 17. – 19.10.2019, Hannover; 17. – 19.10.2019; Hannover, Deutschland.
[Poster]
Web of Science
Kowdley, KV; Minuk, GY; Pagadala, MR; Gulamhusein, A; Swain, MG; Neff, GW; Zogg, D; Bowlus, CL; Agarwal, K; Yoshida, EM; Li, Y; Li, G; Chung, CH; Subramanian, M; Myers, RP; Sheikh, AM; Shiffman, ML; Fickert, P
THE NONSTEROIDAL FARNESOID X RECEPTOR (FXR) AGONIST CILOFEXOR IMPROVES LIVER BIOCHEMISTRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
HEPATOLOGY. 2019; 70: 31A-32A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA.
[Poster]
Web of Science
Schwetz, V; Schlager, H; Obermayer-Pietsch, B; Stojakovic, T; Fauler, G; Fickert, P; Zollner, G
Alteration of glucocorticoid metabolism in patients with cholestasis
J HEPATOL. 2019; 70: E417-E418.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA.
Doi: 10.1016/S0618-8278(19)30822-9
[Poster]
Web of Science
FullText
FullText_MUG
Tewes, B; Trauner, MH; Steinacher, D; Fickert, P; Stiess, M; Zimmermann, T; Greinwald, R
NORURSODEOXYCHOLIC ACID (NORUDCA) SIGNIFICANTLY AMELIORATES LIVER INJURY IN THE STAM MOUSE MODEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)
HEPATOLOGY. 2019; 70: 1298A-1299A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA.
[Oral Communication]
Web of Science
Aberer, F.; Manninger-Wünscher, M; Rainer, F.; Artinger, K.; Rehatschek, H.; Hye, F.; Pieber, Th. R.; Fickert, P.; Hammer, H.; Lang-Loidolt, D.; Roller-Wirnsberger, R.;
Teaching of Clinical Reasoning in Internal Medicine in Blended Learning format integrated in the Curriculum of the Medical University of Graz
In proceedings of the 22nd Grazer conference. 2018; 40-41.-Grazer Konferenz; APR 5-7, 2018; Maribor, Slovenia. (ISBN: 978-3-200-05654-1 )
[Poster]
FullText
Al-Dury, S; Wahlstrom, A; Katrin, P; Anders, T; Stahlman, M; Olsson, L; Trauner, M; Fickert, P; Moore, D; Backhed, F; Fandriks, L; Wagner, M; Marschall, HU
FXR agonist obeticholic acid increases gallbladder FGF19 in gallstone patients
J HEPATOL. 2018; 68: S449-S449.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)31140-1
[Oral Communication]
Web of Science
FullText
FullText_MUG
Al-Dury, S; Wahlstrom, A; Panzitt, K; Thorell, A; Stahlman, M; Trauner, MH; Fickert, P; Backhed, F; Fandriks, L; Wagner, M; Marschall, HU
Obeticholic Acid Increases Cholesterol Saturation and FGF19 in Human Gallbladder Bile
HEPATOLOGY. 2018; 68: 159A-159A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA.
[Oral Communication]
Web of Science
Fickert, P
Update HCC
; NOV 22, 2018; Fürstenfeld, AUSTRIA. 2018.
[Keynote lecture]
Fickert, P
Extrahepatic effects of bile acids in cholestasis
XXV International Bile Acid Meeting: Bile Acids in Health and Disease 2018; JUL 6-7, 2018; Dublin, IRELAND. 2018.
[Keynote lecture]
Fickert, P
Loxl2 and bile ducts a dangerous liaison?
17th Hepatobiliary and Gastrointestinal Research Retreat; JAN 12-14, 2018; Les Diablerets, SWITZERLAND. 2018.
[Keynote lecture]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Hepato Update 2018; APR 27-28, 2018; Berlin, GERMANY. 2018.
[Keynote lecture]
Fickert, P
HCC Advisory Board
HCC Advisory Board; SEP 24, 2018; Vienna, AUSTRIA. 2018.
[Keynote lecture]
Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
51. Jahrestagung der ÖGGH; Juni 14 - 16, 2018; Salzburg, AUSTRIA. 2018.
[Oral Communication]
Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J
New Liver Biomarker
102. Annual Meeting of the German Society of Pathology. 2018; -102. Annual Meeting of the German Society of Pathology; May, 2018; Berlin.
[Poster]
Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Changes in the intestinal microbiome during a multispecies probiotic intervention in compensated cirrhosis
Theodor Escherich Symposium; NOV 8-9, 2018; Graz, Austria. 2018.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fickert, P; Rinner, B; Haybäck, J;
Die Rolle des Interleukin-6 Rezeptors im Zuge der Cholangiozellulären Karzinogenese.
Jahrestagung der Deutschen Gesellschaft für Pathologie. 2018; -102. Jahrestagung der DGP; MAI 24-28, 2018; Berlin.
[Poster]
Komarova, I; Horvath, A; Krones, E; Fickert, P; Leber, B; Schmerböck, B; Durchschein, F; Zollner, G; Stauber, R; Spindelboeck, W;
Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Stadlbauer, V
Bile acids composition and neutrophil function in different etiologies of liver cirrhosis.
JOINT DK-RETREAT MCBO/MOLIN/IAI “Cancer, Inflammation, Immunity”; JAN 13-17, 2018; Universitätszentrum OBERGURGL, Tirol, AUSTRIA. 2018.
[Poster]
Komarova, I; Horvath, A; Krones, E; Leber, B; Schmerboeck, B; Durchschein, F; Zollner, G; Stauber, R; Spindelboeck, W; Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Fickert, P; Stadlbauer, V
Functional response of neutrophils is associated with serum bile acids profile in liver cirrhotic patients
Zeitschrift für Gastroenterologie. 2018; 56(05):e28-e28.-51. ÖGGH Jahrestagung; JUN 14–16, 2018; Salzburg, AUSTRIA.
[Oral Communication]
FullText
Pollheimer, M; Racedo, S; Mikels-Vigdal, A; Bowlus, C; Lackner, C; Karlsen, TH; Hov, JR; Lyman, SK; Adamkewicz, J; Smith, V; Moreau, E; Eide, TJ; Stojakovic, T; Stauber, RE; Trauner, M; Fickert, P
Lysyl oxidase-like protein 2 in cholangiopathies
VIRCHOWS ARCH. 2018; 473: S6-S7.-30th European Congress of Pathology; 08-12.09, 2018 ; Bilbao.
[Oral Communication]
Web of Science
Rainer, F; Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Blesl, A; Madl, T; Klymiuk, I; Groselj-Strele, A; Durdevic, M; Gronbaek, H; Moller, HJ; Freedber, DE; Abrams, JA; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome
J HEPATOL. 2018; 68: S700-S700.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)31663-5
[Poster]
Web of Science
FullText
FullText_MUG
Reiberger, T; Fickert, P
TIPS oder Transplantation im Management der Portalen Hypertension
Lebertransplantationskurs; FEB 1-2, 2018; Innsbruck, AUSTRIA. 2018.
[Oral Communication]
Sassmann, T; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Revelant, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P
Diastolic dysfunction and cardiopulmonary exercise capacity in patients with advanced liver disease-results from a prospective cross-sectional cohort
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):627-627.-ÖGP Jahrestagung; OKT 18-20, 2018; Linz, Austria.
[Poster]
Web of Science
Sassmann, T; Kovacs, G; Stauber, RE; Revelant, F; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P;
Impact of diastolic dysfunction on exercise capacity in patients with liver cirrhosis
European Respiratory Journal. 2018; 52(sup 62):-ERS International Congress; SEP 15 - 19, 2018; Paris, France.
Doi: 10.1183/13993003.congress-2018.PA2486
[Poster]
Web of Science
FullText
FullText_MUG
Tiefenbacher, P; Sendlhofer, G; Fickert, P;
Unterstützende, tabletbasierte Patientenaufklärung –
Steigerung der Aufklärungsqualität
https://oepgk.at/wp-content/uploads/2018/01/4.-%C3%96PGK-Konferenz-Sammelband-der-Konferenzbeitr%C3%A4ge.pdf. 2018; -4. ÖPGK Konferenz; 24.10.2018; Graz, AUSTRIA.
[Keynote lecture]
FullText
Blesl, A; Horvath, A; Jungst, C; Leber, B; Schmerboeck, B; Tawdrous, M; Stiegler, P; Rainer, F; Spindelboeck, W; Fickert, P; Lammert, F; Reichert, M; Stadlbauer, V.
Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP)
J HEPATOL. 2017; 66(1):S354-S355.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31046-2
[Poster]
Web of Science
FullText
FullText_MUG
Blesl A; Horvath, A; Jüngst, Ch; Leber, B; Schmerböck, B; Tawdrous, M; Stiegler, P; Rainer, F; Spindelböck, W; Fickert, P; Lammert, F; Stadlbauer, V
Impaired gut permeability and alterations of the gut microbiota in secondary sclerosing cholangitis of critically ill patients (SSC-CIP)
ÖGIAIN; JUN 7-10, 2017; Innsbruck. 2017.
[Poster]
Douschan, P; Kovacs, G; Stadlbauer, V; Kniepeiss, D; Krones, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Zollner, G; Avian, A; Fickert, P; Olschewski, A; Olschewski, H; Stauber, RE
Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension - results from a prospective cross-sectional study
J HEPATOL. 2017; 66(1):S568-S569.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31556-8
[Poster]
Web of Science
FullText
FullText_MUG
Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Sassmann, T; Revelant, F; Stadlbauer, V; Kniepeiss, D; Fickert, P; Avian, A; Olschewski, A; Olschewski, H
Impact of chronic liver disease on pulmonary hemodynamics and exercise tolerance - results from a prospective cross-sectional study
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):768-769.
[Poster]
Web of Science
Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer-Kollner, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H
Exercise Hemodynamics In The Screening For Pulmonary Vascular Disease In Patients With Portal Hypertension - Results From A Prospective Cross-Sectional Study
AM J RESP CRIT CARE. 2017; 195: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2017; Washington, USA.
[Oral Communication]
Web of Science
Fickert, P
Neue Konzepte bei immunologischen und cholestatischen Lebererkrankungen.
FALK Gastro Forum 2017; OCT 14, 2017; Salzburg, AUSTRIA. 2017.
[Keynote lecture]
Fickert, P
Advances in managament of patients with PSC
1st Symposium Hepatology 2017; FEB 23, 2017; Bern, SWITZERLAND. 2017.
[Keynote lecture]
Fickert, P
Post Graduate Course: A multidisciplinary Approach to Patients with Liver Diseases
Abstracts of The International Liver CongressTM 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. 2017; 66(1):1-876.-EASL The International Liver Congress 2017; APR 19-23, 2017; Amsterdam, THE NETHERLANDS.
[Oral Communication]
Fickert, P
Lebertransplantation bei alkoholischer Fettleberhepatitis
ÖGGH Lebertransplantationskurs; Feb 3, 2017; Innsbruck, AUSTRIA. 2017.
[Oral Communication]
Fickert, P
Autoimmune Lebererkrankungen - Update 2017.
Autoimmune Lebererkrankungen - Update 2017; JUN 20, 2017; Graz, AUSTRIA. 2017.
[Keynote lecture]
Fickert, P
Ambivalenz in der Medizin
Out of the Box; DEZ 5, 2017; Vienna, AUSTRIA. 2017.
[Keynote lecture]
Fickert, P
Bile Acid-Induced Nephropahty.
Full Abstracts of EASL Monothematic Conference 2017. 2017; -EASL Monothematic Conference: Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments.; JUN 9-11, 2017; Oslo, NORWAY.
[Oral Communication]
Fickert, P
Hepatologie.
Facharztprüfung Innere Medizin; AUG 24-26, 2017; Krems, AUSTRIA. 2017.
[Keynote lecture]
Fickert, P
Langzeitmanagement nach Lebertransplantation: Härter als gedacht.
31. Jahrestagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik 2017; OCT 18-20, 2017; Zell am See, AUSTRIA. 2017.
[Keynote lecture]
Fickert, P
Management von Puritus bei Lebererkrankungen.
48. Jahrestagung der ÖGIM 2017; SEP 21-23, 2017; Salzburg, AUSTRIA. 2017.
[Keynote lecture]
Fickert, P
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch Hepatologie 2017. 2017; -Hepato Update 2017; MAY 19-20, 2017; Berlin, GERMANY. (ISBN: 978-3-86302-460-4 )
[Keynote lecture]
Fickert, P; Reiberger, T
Definitionen der portalen Hypertension
3. Konsensuskonferenz Portale Hypertension; FEB 18, 2017; Vienna, AUSTRIA. 2017.
[Keynote lecture]
Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Lackner, K; Puntschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade colon and rectum carcinoma
EUR J CANCER. 2017; 72: S57-S57.-ECCO European Cancer Congress; JAN 27-30, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0959-8049(17)30267-8
[Oral Communication]
Web of Science
FullText
FullText_MUG
Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kammerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade and colon and rectum carcinoma
VIRCHOWS ARCH. 2017; 471: S167-S167.
[Poster]
Web of Science
Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P, Haybaeck J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
2017. 2017; -European Congress of Pathology; Sep 2.-6., 2017; Amsterdam.
[Poster]
Golob-Schwarzl, N; Krassnig, S; Park, Y; Gogg-Kamerer, M; Wodlej, C; Vierlinger, K; Schroeder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J
PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors as new biomarkers in liver cancer
VIRCHOWS ARCH. 2017; 471: S164-S164.
[Poster]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H;Regenbrecht,C; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J,
Eukaryotic Initiation factors (eIFs) in colorectal carcinoma
19th International AEK Cancer Congress 2017 ; 1 – 3 March 2017 ; Heidelberg, GERMANY. 2017.
[Poster]
Horvath, A; Bashir, M; Schmerboeck, B; Rainer, F; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Leber, B; Stadlbauer, V
Intestinal colonisation by Veillonella spp. is predictive for mortality in stable cirrhosis and could be partially reduced by a multispecies probiotic in a randomized placebo controlled trial
J HEPATOL. 2017; 66(1):S128-S128.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)30524-X
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Durdevic, M; Leber, B; Schmerboeck, B; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer V
Multispecies probiotic enriches the microbiome with Lactobacillus and Lactococcus and reduces Enterococcus abundance in patients with liver cirrhosis: Results of a randomized, double-blind, placebo-controlled trial.
Volume 5, Issue 5_suppl, October 2017. 2017; -UEG Week 2017; OCT 28-NOV 1, 2017; Barcelona.
[Poster]
Horvath, A; Grande, P; Rainer, F; Blesl, A; Meinitzer, A; Leber, B; Schmerböck, B; Komarova, I; Fickert, P; Stiegler, P; Wagner, M; Stadlbauer, V
FGF21 in acute and chronic alcohol consumption
Zeitschrift für Gastroenterologie, Ausgabe 05, Volume 55, Mai 2017. 2017; -Jahrestagung der ÖGGH; JUN 9-10 2017; Linz.
[Poster]
Horvath, A; Rainer, F; , Bashir, M; Leber, B; Schmerboeck, B; Grønbæk, H; Møller, HJ; Madl, T; Groselj-Strele, A; Fickert, P; Stiegler, P; Stadlbauer, V
LONG-TERM PROTON PUMP INHIBITOR USE INCREASES INTESTINAL DYSBIOSIS, GUT PERMEABILITY, INFLAMMATION AND MORTALITY IN PATIENTS WITH LIVER CIRRHOSIS.
UEG Journal, Volume: 5 issue: 5_suppl, page(s): A1-A160. 2017; -UEG Week 2017; OCT 28-NOV 1, 2017; Barcelona.
[Oral Communication]
Horvath, A; Rainer, F; Bashir, M; Leber, B; Schmerboeck, B; Grønbæk, H; Madl, T; Fickert, P; Stiegler, P; Stadlbauer, V
Protonenpumpenhemmer bei Leberzirrhose: Einfluss auf Dysbiose, Darmpermeabilität, Inflammation und Mortalität
Zeitschrift für Gastroenterologie, Ausgabe 05, Volume 55; Mai 2017. 2017; -Jahrestagung der ÖGGH; JUN 9-10 2017; Linz, Austria.
[Oral Communication]
Jungst, C; Stadlbauer, V; Reichert, M; Weber, S; Ofner-Ziegenfuss, L; Voigtlander, T; Spindelbock, W; Fickert, P; Kirchner, G; Lammert, F; Lankisch, TO; Krawczyk, M
NOD2 variants as novel genetic risk factors for secondary sclerosing cholangitis in critically ill patients
J HEPATOL. 2017; 66(1):S358-S358.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J
Interleukin-6 Receptor influences cholangiocarcinoma progression
VIRCHOWS ARCH. 2017; 471: S325-S326.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands.
[Poster]
Web of Science
Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Rose-John, S; Fickert, P; Haybaeck, J;
Die Expression des Interleukin 6 Rezeptors hat Auswirkungen auf das Cholangiozelluläre Karzinom.
101. Jahrestagung der deutschen Gesellschaft für Pathologie . 2017; JUN 22-24; Erlangen, GERMANY.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Rinner, B; Thalhammer, M; Aigelsreiter, A; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J;
The Role of Interleukin-6 Receptor Signaling in Cholangiocarcinoma
Proceedings of the Doctoral Day. 2017; -Proceedings of the Doctoral Day.; DEC 13, 2017; Graz, Austria.
[Poster]
Leber, B; Horvath, A; Schmerbock, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C
J HEPATOL. 2017; 66(1):S293-S293.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)30902-9
[Poster]
Web of Science
FullText
FullText_MUG
Leber, B; Horvath, A; Schmerböck, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelböck, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Neutrophil phagocytic capacity in chronic hepatitis C improves under direct acting antivirals
Zeitschrift für Gastroenterologie. 2017; 55(5):-ÖGGH; JUN 8-10, 2017; Linz, Austria.
[Poster]
Moustafa, T; Fickert, P
Kongressbericht zum Keystone Bile Acid Receptor Meeting
Keystone Bile Acid Receptor Meeting; MAR 3-7, 2017; Monterey, USA. 2017.
Moustafa, T; Zaufel, A; Eichmann, T; Kolb-Lenz, D; Trauner, M; Fickert, P
Regulation of the mechanistic target of rapamycin complex 1 (mTORC1) - nuclear hormone receptor signaling by bile acids
J HEPATOL. 2017; 66(1):S111-S111.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)30481-6
[Poster]
Web of Science
FullText
FullText_MUG
Panzitt, K; Marschall, HU; Trauner, M;Fickert, P; Wagner, M
The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone. 2017; -Keystone bile acid meeting; March 5-9, 2017; Monterey, USA.
[Poster]
Rainer, F; Horvath, A; Sandahl, TD; Leber, B; Schmerboeck, B; Blesl, A; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Moller, HJ; Gronbaek, H; Stadlbauer, V
Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis
J HEPATOL. 2017; 66(1):S368-S369.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31080-2
[Poster]
Web of Science
FullText
FullText_MUG
Stadlbauer, V; Schmerbock, B; Leber, B; Kipperer, M; Stiegler, P; Posch, A; Streit, A; Spindelbock, W; Fickert, P; Stauber, R
Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C
J HEPATOL. 2017; 66(1):S710-S711.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31903-7
[Poster]
Web of Science
FullText
FullText_MUG
Traussnigg, S; Schattenberg, JM; Demir, M; Wiegand, J; Geier, A; Teuber, G; Hofmann, WP; Kremer, AE; Spreda, F; Kluwe, J; Petersen, J; Boettler, T; Halilbasic, E; Greinwald, R; Proels, M; Manns, MP; Fickert, P; Trauner, MH
norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study
HEPATOLOGY. 2017; 66: 106A-107A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC.
[Oral Communication]
Web of Science
Bowe, A; Hoffmann, V; Curth, HM; Fickert, P; Nierhoff, D;
CHOLESTASIS INDUCES EXPRESSION OF THE ONCOFETAL MARKER NOPE IN ADULT MURINE LIVER INDEPENDENT OF FXR.
J HEPATOL. 2016; 64: S427-S427.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(16)00692-9
[Oral Communication]
Web of Science
FullText
FullText_MUG
Fickert, P
Bile acid-mediated liver injury
IPSCSG Study Group Meeting; Jun 06, 2016; New Haven, USA. 2016.
[Keynote lecture]
Fickert, P.
Cholangiocyte Biologie: a source for the therapy of chronic cholestatic diseases
International Liver Conference, EASL; APR 13-17, 2016; Barcelona, SPAIN. 2016.
[Keynote lecture]
Fickert, P.
Novel Therapeutics Options for PSC and PBC
Falk Symposium 205 "New Treatment Targets in Gut and Liver Diseases"; Oct 21-22, 2016; Luzern, SWITZERLAND. 2016.
[Oral Communication]
Grgic-Mustafic, R; Kahn, J; Podbregar, M; Holobar, A; Stauber, R; Fickert, P; Stadlbauer-Kollner, V; Nwoha, B; Muller, H; Kniepeiss, D
A NEW METHOD FOR THE DETERMINATION AND MONITORING OF THE AMMONIA IN THE EXHALED AIR
TRANSPL INT. .. 2016; 29: 18-18.
[Poster]
Web of Science
Grgic-Mustafic R, Kahn J, Podbregar M, Holobar A, Stauber R, Fickert P, Stadlbauer-Köllner V, Nwoha B, Müller H, Kniepeiss D
Eine neue Methode zur Bestimmung und Monitoring des Ammoniaks in der Ausatemluft
Special Issue: 30th Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics . 2016; 29(S4):1-23.-Austrotransplant; OKT 19-21, 2016; Schladming.
[Poster]
Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Tawdrous, M; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Probiotic modulation of gut microflora in cirrhosis: Influence on Lactobacilli and Veillonella
Microbiome Science Days; OCT 7-8, 2016; Bertesgaden, Germany. 2016.
[Oral Communication]
Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V
Multispecies probiotic maintains health related quality of life in cirrhosis better than placebo
Journal of Hepatology. 2016; 64(2):425-629.-EASL - ILC2016; APR 12-17, 2016; Barcelona, SPAIN.
[Poster]
Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V;
MULTISPECIES PROBIOTIC MAINTAINS HEALTH RELATED QUALITY OF LIFE IN CIRRHOSIS BETTER THAN PLACEBO.
J HEPATOL. 2016; 64: S249-S249.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(16)00262-2
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Zettel, G; Hartl, A; Madl, T; Stryeck, S; Fuchs, D; Lemesch, S; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Rainer, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
A multispecies probiotic enhances antimicrobial activity in cirrhosis: A randomized, double blind placebo-controlled study
Zeitschrift für Gastroenterologie . 2016; (5):385-520.-Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 16-18, ; Wien.
[Poster]
Jungst, C; Stadlbauer, V; Reichert, MC; Ofner-Ziegenfuss, L; Voigtlander, T; Spindelboeck, W; Fickert, P; Kirchner, GI; Lammert, F; Lankisch, T; Krawczyk, M
NOD2 confers risk for sclerosing cholangitis in critically ill patients: genetic study in two independent cohorts
HEPATOLOGY. 2016; 63(1 SUPP):191A-192A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA.
[Poster]
Web of Science
Krones, E; Bork, T; Grahammer, F; Wagner, M; Rosenkranz, AR; Huber, TB; Fickert, P
ACCUMULATION OF LC3 II IN CHOLEMIC NEPHROPATHY IS CAUSED BY BLOCKAGE OF AUTOPHAGIC FLUX
NEPHROL DIAL TRANSPL. 2016; 31: 103-104.-53rd ERA-EDTA Congress; MAY 21-24, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
Leopold, C; Vujić, N; Rainer, S; Gumhold, J; Pollheimer, M; Radović, B; Fickert, P; Kratky, D;
Consequences of lysosomal acid lipase deficiency on lipid and carbohydrate metabolism
6th International Graz Symposium on Lipid and Membrane Biology; 7-9, 2016; Graz, AUSTRIA. 2016.
[Poster]
Leopold, C; Vujić, N; Rainer, S; Gumhold, J; Pollheimer, M; Radović, B; Fickert, P; Kratky, D;
Consequences of lysosomal acid lipase deficiency on lipid and carbohydrate metabolism
Lipid Droplets: Dynamic Organelles in Metabolism and Beyond; FASEB Meeting;; JUL 24-19,2016; Snowmass Village, CO, USA. 2016.
[Poster]
Liu, L; Zaufel, A; Gumhold, J; Krones, E; Zollner, G; Fickert, P
Molecular regulation of adrenal function by bile acids
Proceedings of the XXIV International Bile Acid Meeting. 2016; -XXIVInternational Bile Acid Meeting; JUN 17-18, 2016; Düsseldorf, Germany.
[Poster]
Liu, L; Zaufel, A; Zollner,G; Fickert, P
Molecular regulation of adrenal glands by bile acids
6th DK-MCD Scientific Retreat; October 19-21,2016; Seggauberg, Austria. 2016.
[Poster]
Panzitt, K; Marschall, HU; Moore, DD; Trauner, MH; Fickert, P; Wagner, M
The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
HEPATOLOGY. 2016; 63(1 SUPP):159A-159A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA.
[Poster]
Web of Science
Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner,M;
The autophagy inhibitor Rubicon is a direct FXR target in human liver and is induced in human cholestasis
Proceedings of the XXIV International Bile Acid Meeting. 2016; -XXIV International Bile Acid Meeting: Bile Acids in Health and Disease; JUN 17-18, 2016; Düsseldorf, GERMANY.
[Poster]
Panzitt,K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M;
The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone Symposia Abstract Book "Autophagy: Molecular and physiological mechanisms". 2016; -Autophagy: Molecular and Physiological Mechanisms (V1); JUN 5-9, 2016; Whistler, British Columbia, CANADA.
[Poster]
Schaffellner, S; Stauber, R; Sereinigg, M; Muller, H; Fickert, P; Hogenauer, C; Krumnikl, J; Lackner, C; Stadlbauer, V; Kniepeiss, D
THE DOSE MAKES THE POISON: ACUTE LIVER FAILURE AFTER VITAMIN B3 OVERDOSAGE
TRANSPL INT. .. 2016; 29: 11-11.
[Poster]
Web of Science
Stadlbauer, V; Fickert, P; Zink, M
DEVELOPMENT OF AN APP TO FACILITATE AND IMPROVE THE ORGANIZATIONAL PROCESS IN ORGAN DONATION
TRANSPL INT. .. 2016; 29: 10-10.
[Poster]
Web of Science
Trauner, M; Fickert, P; Hirschfield, G; Reiter, F; Altorjay, I; Marschall, U; Farkkila, M; Schramm, C; Spengler, U; Chapman, R; Bergquist, A; Schrumpf, E; Nevens, F; Halilbasic, E; Greinwald, R; Proels, M; Manns, MP;
NORURSODEOXYCHOLIC ACID IMPROVES CHOLESTASIS IN PRIMARY SCLEROSING CHOLANGITIS: RESULTS OF A PHASE II DOSE FINDING STUDY.
J HEPATOL. 2016; 64: S208-S209.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(16)00171-9
[Oral Communication]
Web of Science
FullText
FullText_MUG
Trauner, MH; Fickert, P; Hirschfield, G; Denk, G; Altorjay, I; Marschall, HU; Farkkila, MA; Schramm, C; Spengler, U; Chapman, RW; Bergquist, A; Schrumpf, E; Nevens, F; Halilbasic, E; Greinwald, R; Prols, M; Manns, MP
norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response
HEPATOLOGY. 2016; 63(1 SUPP):111A-111A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA.
[Oral Communication]
Web of Science
Baghdasaryan.A; Offner-Ziegenfuß, L; Gumhold, J; Fickert, P; Jahnel, J; Resch, B; Deutschmann,A
Assoziation zwischen einer heterozygoten ABCB11-Mutation und einer transienten neonatalen Cholestase nach peripartaler Asphyxie
Monatsschrift Kinderheilkd . 2015; Suppl 3(163):199-200.-53. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; SEP 24-26, 2015; Eisenstadt.
[Poster]
Bersuch, LA; Krones, E; Wenzl, H; Fickert, P
Häufigkeit und Differentialdiagnosen einer erhöhten alkalischen Phosphatase bei PatientInnen mit CED an der Universitätsklinik für Innere Medizin Graz
48. OEGGH Jahrestagung 2015; JUN 18-20, 2015; Salzburg, Austria. 2015.
[Poster]
Bowe, A; Hoffmann, V; Curth, HM; Fickert, P; Nierhoff, D
CHOLESTASIS AND BILE ACIDS INDUCE EXPRESSION OF THE ONCOFETAL MARKER Nope IN ADULT MURINE HEPATOCYTES INDEPENDENT OF FXR
J HEPATOL. 2015; 62: S799-S799.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(15)31382-9
Web of Science
FullText
FullText_MUG
Fickert, P;
Krankheitsbilder der Gallenblase
ÖGIM FLIP 2015 - Fortbildung Live Internet Print: Leber; JUN 15, 2015; Vienna, AUSTRIA. 2015.
[Oral Communication]
Fickert, P;
Autoimmune Leber- und Gallenwegserkrankungen
Handbuch Hepatologie 2015. 2015; -Hepato Update 2015; MAY 8-9, 2015; Berlin, GERMANY. (ISBN: 978-3-86302-200-6 )
[Keynote lecture]
Fickert, P;
Leberzirrhose
Jahrestagung der Österreichischen Gesellschaft für Innere Medizin 2015; SEP 24-26, 2015; Salzburg, AUSTRIA. 2015.
[Oral Communication]
Fickert, P;
Management von Lebertransplantations-Patienten auf der Warteliste
ÖGGH Lebertransplantationskurs 2015; JAN 29-30, 2015; Innsbruck, AUSTRIA. 2015.
[Oral Communication]
Fickert, P;
Die Leber brennt - Wann muss der Leberpatient ins Krankenhaus?
ÖMCCV UPDATE XIII – Chronisch entzündliche Darmerkrankungen und Hepatologie; MAR 21, 2015; Leoben, AUSTRIA. 2015.
[Oral Communication]
Fickert, P;
Cholestatische Lebererkrankungen
Post AASLD Meeting 2015; JAN 9-10; 2015; Linz, AUSTRIA. 2015.
[Oral Communication]
Fickert, P;
Hepatologie für Anästhesisten
Facharztausbildung Anästhesisten 2015; APR 14, 2015; Salzburg, AUSTRIA. 2015.
[Oral Communication]
Fickert, P;
Meisterkurs/Kolloqium SFB 974 Düsseldorf
Meisterkurs/Kolloqium SFB 974 Düsseldorf; DEC 1-2, 2015; Düsseldorf, GERMANY. 2015.
[Keynote lecture]
Fickert, P;
ASH und NASH
Jahrestagung der Österreichischen Gesellschaft für Innere Medizin 2015; SEP 24-26, 2015; Salzburg, AUSTRIA. 2015.
[Oral Communication]
Horvath, A; Leber, B; Krones, E; Zollner, G; Durchschein, F; Spindelboeck, W; Lemesch, S; Douschan, P; Fauler, G; Stojakovic, T; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V
SERUM BILE ACIDS IN CIRRHOSIS DEPEND ON AETIOLOGY.
J HEPATOL. 2015; 62(S2):S344-S344.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(15)30336-6
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Leber, B; Krones, E; Zollner, G; Fickert, P; Stauber, RE; Lemesch, S; Spindelboeck, W; Durchschein, F; Douschan, P; Stiegler, P; Stojakovic, T; Fauler, G; Stadlbauer, V
Serum bile acids in cirrhosis depend on aetiology.
Z Gastroenterol. 2015; 53(5):512-512.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA.
[Poster]
Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Hartl, A; Lemesch, S; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Spindelboeck, W; Oettl, K; Payerl, D; Stadlbauer, V
Probiotic supplementation improves liver function but fails to restore neutrophil phagocytosis in stable cirrhosis. A randomized, double-blind, placebo-controlled study
HEPATOLOGY. . 2015; 62: 1216A-1216A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA.
[Oral Communication]
Web of Science
Krones E., Rainer F., Blesl A., Pollheimer M., Zollner G., Fickert P.
Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)
OEGGH Jahrestagung; 19-20 Juni; Salzburg. 2015.
[Poster]
Leber, B; Stadlbauer, V; Lemesch, S; Trajanoski, S; Bashir, M; Sinnitsch, A; Horvath, A; Tawdrous, M; Stojakovic, T; Gauler, G; Fickert, P; Högenauer, C; Klymiuk, I; Stiegler, P; Lamprecht, M; Pieber; TR, Tripolt, NJ, Sourij, H
Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome
Zeitschrift für Gastroenterologie. 2015; -48. Jahrestagung der ÖGGH; JUN 19-20; Salzburg, Austria.
[Poster]
Leopold, C; Vujić, N; Rainer, S; Fickert, P; Gumhold, J; Pollheimer, M; Radović, B; Kratky,D
Consequences of lysosomal acid lipase deficiency on lipid and carbohydrate metabolism
5th Scientific Retreat of the Doctoral College for Cardiovascular and Metabolic Diseases (DK-MCD); OKT 28-30, 2015; Seggau Castle, AUSTRIA. 2015.
[Oral Communication]
Leopold, C; Vujić, N; Rainer, S; Gumhold, J; Pollheimer, M; Radović, B; Fickert, P; Kratky, D;
Consequences of lysosomal acid lipase deficiency on lipid and carbohydrate metabolism.
Doctoral Day 2015; DEZ 11, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Liu, L; Zaufel, A; Zollner, G; Fickert, P
Molecular regulation of adrenal function by bile acids
5th scientific DK-MCD retreat; Oct 28-30, 2015; Leibnitz, AUSTRIA. 2015.
[Poster]
Liu, L; Zaufel, A; Zollner, G; Fickert, P
Molecular regulation of adrenal glands by bile acids
5th scientific DK-MCD retreat; Oct 28-30, 2015; Leibnitz, AUSTRIA. 2015.
[Oral Communication]
Liu, L; Zaufel, A; Zollner, G; Fickert, P
Molecular regulation of adrenal function by bile acids
2015 Med Uni Graz Doctoral Day; Dec 11, 2015; 2015.
[Poster]
Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M;
Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
UEG Journal. 2015; -UEG Week 2015; 24.10. - 28.10.2015; Barcelona.
[Poster]
Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M;
Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber
ÖGGH Jahrestagung 2015; 18.6. - 20.6.2015; Salzburg. 2015.
[Poster]
Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M;
Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
Hepatology. 2015; -AASLD 2015; 13.11. - 17.11.2015; San Francisco.
[Poster]
Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M
Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
HEPATOLOGY. . 2015; 62: 538A-538A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA.
[Oral Communication]
Web of Science
Wilhelmer, P; Krones, E; Racedo, SM; Fickert, P
Differentielle Effekte von Gallensäuren auf Tubulus- und Sammelrohrepithelzellen
48. OEGGH Jahrestagung 2015; Jun 18-20, 2015; Salzburg, Austria . 2015.
[Poster]
Baghdasaryan A, Jha P, Müller M, Agostinelli L, Saccomanno S, Auer N, Deutschmann A, Zöhrer C, Auwerx J, Marzioni M, Fickert P, Trauner M.
Protective role of membrane bile acid receptor TGR5 (GPBAR1) in DDC-induced sclerosing cholangitis in mice
Journal of Hepatology, Volume 60, Issue 1, Supplement, April 2014, Pages S197-S198. 2014; -The International Liver Congress 2014. 49th annual meeting of the European Association for the Study of the Liver; APR 9-13, 2014; London, UK.
[Poster]
FullText
Baghdasaryan A, Jha P, Müller M, Auer N, Deutschmann A, Zöhrer, Ingrid Påhlman, Hans Graffner, Fickert P, Trauner M
Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250protects against bile acid-mediated liver injury in cholestasis
Journal of Hepatology, Volume 60, Issue 1, Supplement, April 2014, Page S57 . 2014; -The International Liver Congress 2014. 49th annual meeting of the European Association for the Study of the Liver; APR 9-13, 2014; London, UK.
[Oral Communication]
FullText
Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Fickert, P; Olschewski, H; Stauber, RE
CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH PORTAL HYPERTENSION AND EARLY STAGE LIVER DISEASE.
Journal of Hepatology. 2014; 60(1):236-236.-International Liver Congress / 49th Annual meeting of the European Association for the Study of the Liver ; April 9 - 13, 2014; London, ENGLAND.
[Poster]
Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Wagner, M; Fickert, P; Olschewski, H; Stauber, RE
Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis.
Z Gastroenterol. 2014; 52 - P66: -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); 12. – 14. Juni, 2014; Villach, AUSTRIA.
[Poster]
Fickert, P;
Role of animal models in PBC
EASL Monothematic Conference: Primary Biliary Cirrhosis (PBC); May 23-24, 2014; Mailand, ITALY. 2014.
[Keynote lecture]
Fickert, P;
Cholemic nephropathy
XXIII International Bile Acid Meeting 2014; Okt 8-9, 2014; Freiburg, GERMANY. 2014.
[Keynote lecture]
Fickert, P;
Characterisation of PSC animal models
3rd IPSCSG WORKSHOP; Jun 23-24, 2014; 2014.
[Keynote lecture]
FullText
Hofer, H; Zollner, G; Fickert, P; Graziadei, I; Trauner, M
Clinical Course And Outcome Of Patients With Sclerosing Cholangitis In Critically Ill Patients (Sc-Cip): High Mortality Without Liver Transplantation
HEPATOLOGY. 2014; 60: 354A-354A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA.
[Poster]
Web of Science
Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, RE; Fickert, P; Zollner, G; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Stadlbauer, V
Neutrophil dysfunction in liver cirrhosis despite sufficient opsonisation
Z Gastroenterol 2014; 52 - P62. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, Austria.
[Poster]
Horvath, A; Leber, B; Lemesch, S; Suppan, O; Yuksel, O; Sherzay, K; Zettel, G; Tawdrous, M; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V
LISTING FOR LIVER TRANSPLANT: NO IMPACT ON THE QUALITY OF LIFE
TRANSPL INT. 2014; 27: 20-21.
[Poster]
Web of Science
Horvath, A; Leber, B; Spidelboeck,W; Stiegler, P; Stauber, RE; Lemesch, S; Douschan, P; Durchschein,F; Fickert, P; Krones, E; Zollner, G; Stadlbauer, V
THE NEUTROPHIL CAUGHT BETWEEN CIRRHOSIS, GUT PERMEABILITY AND VIRAL HEPATITIS C.
UEG Journal; October 2014; 2 (1 suppl)
22nd United European Gastroenterology Week Vienna, Austria, October 18-22, 2014 Abstract Issue. 2014; -United European Gastroenterology Week; OCT 18-22, 2014; Vienna, Austria.
[Poster]
Horvath, A; Leber, B; Spindelböck, W; Stiegler, P; Stauber, RE; Lemesch, S; Douschan, P; Durchschein, F; Fickert, P; Krones, E; Zollner, G; Stadlbauer V;
THE NEUTROPHIL CAUGHT BETWEEN CIRRHOSIS, GUT PERMEABILITY AND VIRAL HEPATITIS C.
ZMF 10th Anniversary; JUL 17-18, 2014; Graz, Austria. 2014.
[Oral Communication]
Krones, E; Fritz, J; Schwarz, C; Durchschein, F; Eller, K; Zollner, G; Ribitsch, W; Stojakovic, T; Zitta, S; Buchgraber, J; Eppich, S; Rosenkranz, A; Fickert, P
Pathologische Harnzytologie als Hinweis für strukturelle Nierenschäden bei PatientInnen mit Zirrhose und Cholestase mit normaler Nierenfunktion.
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):566-566.-45. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 25-27, 2014; Salzburg, AUSTRIA.
[Poster]
Web of Science
Krones, E; Fritz, J; Schwarz, C; Durchschein, F; Eller, K; Zollner, G; Ribitsch, W; Stojakovic, T; Zitta, S; Buchgrabner, J; Eppich, S; Rosenkranz, AR; Fickert, P
Increased number of tubular epithelial cells upon urine cytology as a non-invasive test for bile acid-induced kidney injury in cirrhotic and cholestatic patients.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Krones, E; Fritz, J; Schwarz, C; Durchschein, F; Eller, K; Zollner, G; Ribitsch, W; Stojakovic, T; Zitta, S; Buchgrabner, J; Rosenkranz, AR; Fickert, P
Microscopic Urinanalysis May Represent a Sensitive Test for Kidney Injury in Cirrhotic and Cholestatic Patients with Preserved Kidney Function.
HEPATOLOGY. 2014; 60: 328A-328A.-65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 07-11, 2014; Boston, USA.
[Poster]
Web of Science
Krones, E; Glaenzer, D; Durchschein, F; Kirsch, A; Eller, K; Trauner, M; Rosenkranz, AR; Fickert, P
Urinary NGAL Levels Reflect the Therapeutic Effects of norUDCA in Mice with Cholemic Nephropathy
HEPATOLOGY. 2014; 60: 329A-329A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA.
[Poster]
Web of Science
Krones, E; Glanzer, D; Durchschein, F; Kirsch, A; Eller, K; Trauner, M; Rosenkranz, A; Fickert, P
Urinary NGAL Levels reflect the therapeutic Effects of norUDCA in the Mouse Model of cholemic Nephropathy
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):577-577.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA.
[Poster]
Web of Science
Krones, E; Zitta, S; Neunherz, S; Artinger, K; Stojakovic, T; Reibnegger, G; Durchschein, F; Buchgrabner, J; Stadlbauer, V; Fickert, P; Rosenkranz, AR
Chronic Kidney Disease Epidemiology Collaboration Equation combining Creatinine and Cystatin C is superior to other Creatine- and Cystatin C-based Equations in Assessing Renal Function in Patients with Cirrhosis.
HEPATOLOGY. 2014; 60: 325A-325A.-65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 07-11, 2014; Boston, USA.
[Poster]
Web of Science
Krones, E; Zitta, S; Neunherz, S; Artinger, K; Stojakovic, T; Reibnegger, G; Durchschein, F; Stadlbauer-Kollner, V; Fickert, P; Rosenkranz, A
The CKD-EPI Formula, Creatinine and Cystatin C used in combination, is superior to another Creatinine- and Cystatin C based Formulas for Renal Function Determination in Cirrhosis.
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):577-577.-45. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 25-27, 2014; Salzburg, AUSTRIA.
[Poster]
Web of Science
Pontasch, C; Lingitz, K; Fickert, P; Lackner, C; Hauer, A; Birnbacher, R
Fallpräsentation eines 16 ½ jährigen Jugendlichen mit einer primär sklerosierenden Cholangitis, Colitis ulcerosa und Overlap-Autoimmunhepatitis
Tagungsband. 2014; -52. Jahrestagung der ÖGKJ; SEPT 17-19, 2014; Wien .
[Oral Communication]
Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G
Cholestasis and Bile Acids start the Adrenocortical Function, Salzburg, 25th-27th September, 2014
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):570-571.
[Poster]
Web of Science
Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G.
Cholestasis and Bile Acids Alter Adrenocortical Function
Proceedings of the XXIII International Bile Acid Meeting. 2014; -Falk Symposum, XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G.
Cholestasis and Bile Acids Alter Adrenocortical Function
Proceedings of the XXIII International Bile Acid Meeting. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Oral Communication]
A, Horvath; B, Leber; S, Lemesch; P, Stiegler; R, Stauber;
P, Fickert; G, Zollner; W, Spindelboeck; E, Krones;
F, Durchschein; P, Douschan; V, Stadlbauer
INCREASED GUT PERMEABILITY, ELEVATED ENDOTOXIN RELATED PROTEINS AND NEUTROPHIL DYSFUNCTION IN LIVER CIRRHOSIS.
Journal of Hepatology. 2013; 58(S1):S104--48th Annual meeting of the European Association for the Study of the Liver
; 24 April 2013 - 28 April 2013; Amsterdam.
Doi: 10.1016/S0168-8278(13)60246-9
[Poster]
Web of Science
FullText
FullText_MUG
Durchschein, F; Krones, E; Spindelböck, W; Stauber, RE; Lackner, K; Portugaller, H; Stadlbauer-Köllner, V; Fickert, P
Resultate der transarteriellen Chemoembolisation (TACE) bei hepatozellulärem Karzinom (HCC) and der Medizinischen Universität Graz zwischen 2004-2011
Zeitschrift für Gastroenterologie. 2013; 51(05):A8-A8.-ÖGGH Jahrestagung 2013; Jun 13-15, 2013; Graz, AUSTRIA.
[Poster]
Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, R; Fickert, P; Zollner, G; Spindelböck, W; Krones, E; Durchschein, F; Douschan, P; Stadlbauer-Köllner, V
Increased gut permeability, elevated endotoxin related products and neutrophil dysfunction in liver cirrhosis
Z Gastroenterol 2013; 51 - A60. 2013; 51: A60--46. Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); Jun 13-15, 2013; Graz.
[Oral Communication]
FullText
Krones, E; Eller, K; Rosenkranz, A; Deutschmann, A; Kinslechner, K; Durchschein, F; Pollheimer, MJ; Trauner, M; Fickert, P
norUDCA als Therapie der cholämischen Nephropathie
Jahrestagung der osterreichischen Gesellschaften für Hypertensiologie und Nephrologie; SEP 19-21, 2013; Linz, AUSTRIA. 2013.
[Oral Communication]
Krones, E; Pollheimer, MJ; Deutschmann, A; Kinslechner, K; Durchschein, F; Eller, K; Rosenkranz, A; Trauner, M; Fickert, P
norUDCA AMELIORATES CHOLEMIC NEPHROPATHY IN LONG-TERM COMMON BILE DUCT LIGATED MICE
J HEPATOL. 2013; 58: S43-S43.
Doi: 10.1016/S0168-8278(13)60100-2
[Oral Communication]
Web of Science
FullText
FullText_MUG
Krones, E; Pollheimer, MJ; Durchschein, F; Kinslechner, K; Deutschmann, A;Eller, K; Kirsch, A; Rosenkranz, A; Marschall, HU; Trauner, M; Fickert, P
norUDCA - A novel therapeutic option for cholemic nephropathy?
ISC - International Student Congress; JUL 10-12, 2014; Graz, AUSTRIA. 2013.
[Oral Communication]
Leber, B; Tripolt, N; Horvath, A; Lemesch, S; Stojakovic, T; Fauler, G; Stauber, R; Fickert, P; Sourji, H; Stadlbauer-Köllner, V
Gut permeability and serum bile acids in metabolic syndrome
Z Gastroenterol 2013; 51 - A59. 2013; 51(5):A59-501.-46. Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 13-15, 2013; Graz, AUSTRIA.
[Poster]
FullText
Leber, B; Tripolt, N; Lemesch, S; Horvath, A; Stojakovic, T;
Fauler, G; Stauber, R; Fickert, P; Sourij, H; Stadlbauer, V
INCREASED GUT PERMEABILITY IN METABOLIC SYNDROME
IS NOT ASSOCIATED WITH CHANGES IN BILE ACID PROFILE.
J HEPATOL. 2013; 58(S1):S549-S550.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS.
Doi: 10.1016/S0168-8278(13)61366-5
[Poster]
Web of Science
FullText
FullText_MUG
Masser, T; Krones, E; Högenauer, C; Wenzl, HH; Stauber, R; Putz-Bankuti, C; Fickert, P; Zollner, G; Durchschein, F; Stadlbauer-Köllner, V; Spindelböck, W; Petritsch, P; Kump, P
Appendektomie und klinischer Verlauf bei Patienten mit Colitis ulcerosa
ÖGGH Jahrestagung; JUN 13-15, 2013; Graz, AUSTRIA. 2013.
[Poster]
Mueller, M; Marschall, HU; Claudel, T; Wagner, M; Fickert, P; Lackner, C; Einarsson, C; Thorell, A; Trauner, M
URSODEOXYCHOLIC ACID COUNTERACTS LIPOTOXICITY AND INDUCES UNFOLDED PROTEIN RESPONSE IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2013; 58: S517-S517.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(13)61279-9
[Poster]
Web of Science
FullText
FullText_MUG
Pollheimer, MJ; Bowlus, C; Lackner, C; Karlsen, TH; Hov, JR; Lyman, S; Adamkewicz, J; Mikels-Vigdal, A; Marshall, D; Smith, V; Trauner, M; Fickert, P
LYSYL OXIDASE-LIKE 2 (LOXL2) PROTEIN IS INDUCED IN HUMAN CHOLESTATIC LIVER DISEASE AND IN ANIMAL MODELS OF CHOLANGIOPATHIES
J HEPATOL. 2013; 58: S281-S282.
Doi: 10.1016/S0168-8278(13)60696-0
[Poster]
Web of Science
FullText
FullText_MUG
Teckman, J; Fickert, P; Trauner, M
Autophagy is induced by the bile acid norUDCA, which may be a potential therapy for alpha-1-antitrypsin deficiency
HEPATOLOGY. .. 2013; 58: 257A-257A.-64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases; NOV 01-05, 2013; Washington, DC.
[Poster]
Web of Science
Durchschein, F; Pollheimer, MJ; Krones, E; Zollner, G; Trauner, M; Fickert, P
Genetic Loss of Muscarine-3 Receptor Decreases Biliary Bicarbonate Secretion and Aggravates Cholestatic Liver Injury in Mice
HEPATOLOGY. 2012; 56: 334A-334A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science
Durchschein F, Stadlbauer V, Fickert P
Sekundär Sklerosierende Cholangitis nach Polytrauma- Ein Fallbericht und Pathogenetisches Modell
WIT; 18.02.2012; Vienna, Austria. 2012.
[Oral Communication]
Durchschein F., Stadlbauer V., Fickert P.
SEKUNDÄR SKLEROSIERENDE CHOLANGITIS NACH POLYTRAUMA EIN FALLBERICHT UND PATHOGENETISCHES MODELL
WIT - Wiener Intensivmedizinische Tage; Feb 15-18, 2012; Venna, AUSTRIA. 2012.
[Poster]
FullText
Durchschein,F; Pollheimer, M; Krones, E; Zollner, G; Trauner, M; Fickert, P;
DIE ROLLE DES MUSKARINERGEN M3 REZEPTORS FÜR DIE GALLEBILDUNG UND BEI CHOLESTASE IM MODELL DER GALLENGANGSLIGATUR BEI DER MAUS
ÖGGH; 16.06.2012; Wels, Austria. 2012.
[Oral Communication]
Durchschein,F; Pollheimer,M; Krones,E; Zollner,G; Fickert,P
Genetic Loss of Muscarine-3 Receptor Decreases Biliary Bicarbonate Secretion and Aggravates Cholestatic Liver Injury in Mice
Doctoral day; 07.12.2012; Graz, Austria. 2012.
[Oral Communication]
Halilbasic, E; Claudel, T; Bachhofner, N; Kapusta, C; Fickert, P; Trauner, M
Norursodeoxycholic Acid Counteracts Hepatic Acute Phase Response via Modulation of NF kappa B Signaling
HEPATOLOGY. 2012; 56: 539A-540A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science
Krones, E; Pollheimer, MJ; Durchschein, F; Kinslechner, K; Deutschmann, A; Trauner, M; Fickert, P
norUDCA protects common bile duct ligated mice from collecting duct tubular epithelial lesions
Doctoral Day 2012; DEC 7, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
Krones, E; Pollheimer, MJ; Durchschein, F; Trauner, M; Fickert, P
The effects of bile acids on renal collecting duct epithelial cell death - are bile acids the culprits in cholemic nephropathy?
HEPATOLOGY. 2012; 56: 544A-545A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
Krones, E; Pollheimer, MJ; Durchschein, F; Trauner, M; Fickert, P
norUDCA protects CBDL mice from bile acid-induced collecting duct tubular epithelial lesions
Falk Symposium 184
XXII International Bile Acid Meeting
Hepatic and Extrahepatic Targets of Bile Acid Signaling
; SEPT 14 - 15, 2012; Vienna, AUSTRIA. 2012.
[Poster]
FullText
Marschall, HU; Mueller, M; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, C; Thorell, A; Trauner, M
HIGH LEVELS OF URSODEOXYCHOLIC ACID ACT AS FXR ANTAGONIST AND DEPLETE LIVER CHOLESTEROL DUE TO INCREASED BILE ACID SYNTHESIS IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2012; 56: S515-S515.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(12)61319-1
[Poster]
Web of Science
FullText
FullText_MUG
Marzioni, M; Saccomanno, S; Agostinelli, L; Rychlicki, C; Pierantonelli, I; Trauner, M; Fickert, P; Mueller, T; Shanmukhappa, SK; Trozzi, L; De Minicis, S; Candelaresi, C; Svegliati-Baroni, G; Benedetti, A
PDX-1/Hes-1 interaction is a determinant of cholangiocyte proliferative response in Sclerosing Cholangitis
HEPATOLOGY. 2012; 56: 207A-207A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science
Marzioni, M; Saccomanno, S; Agostinelli, L; Rychlicki, C; Pierantonelli, I; Trauner, M; Fickert, P; Muller, T; Shanmukhappa, K; Alpini, G; Trozzi, L; De Minicis, S; Candelaresi, C; Baroni, GS; Benedetti, A
PDX-1/HES-1 INTERACTIONS DETERMINE CHOLANGIOCYTE PROLIFERATIVE RESPONSE TO INJURY: THE SIGNIFICANCE FOR SCLEROSING CHOLANGITIS
J HEPATOL. 2012; 56: S16-S16.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(12)60050-6
Web of Science
FullText
FullText_MUG
Valentin, T; Putz-Bankuti, C; Leitner, E; Talakic, E; Schoellnast, H; Fickert, P; Krejs, GJ; Kessler, HH; Stauber, RE
Pleuro-pulmonary nocardiosis as opportunistic infection in a patient with chronic hepatitis C under combination treatment with pegylated interferon, ribavirin and boceprevir
http://www.oeginfekt.at/download/6-oeik_programm_2012.pdf. 2012; -6. Österreichischer Infektionskongress; APR 18-21, 2012; Saalfelden, AUSTRIA.
[Poster]
Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Adorini, L; Gonzalez, F; Schoonjans, K; Fickert, P; Trauner, M
FXR BUT NOT TGR5 ACTIVATION STIMULATES HCO3-RICH BILE SECRETION AND AMELIORATES LIVER DAMAGE IN MDR2-/- (ABCB4-/-) MOUSE MODEL OF CHRONIC LIVER INJURY
HEPATOLOGY. 2011; 54: 425A-425A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA.
[Oral Communication]
Web of Science
Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Halsegger, S; Adorini, A; Strazzabosco, M; Fickert, P; Trauner, M
Therapeutic Targeting of Nuclear and Membrane Bile Acid Receptors in a Mouse Model of Chronic Cholestasis
; JAN 14-16, 2011; Salzburg, Austria. 2011.
[Oral Communication]
Fickert, P; Silbert, D; Moustafa, T; Halilbasic, E; Krones, E; Durchschein, F; Thueringer, A; Pollheimer, MJ; Zollner, G; Denk, H; Trauner, M
DIFFERENTIAL EFFECTS OF NORUDCA AND UDCA IN OBSTRUCTIVE CHOLESTASIS IN MICE
HEPATOLOGY. 2011; 54: 775A-775A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA.
[Poster]
Web of Science
Fickert, P; Thueringer, A; Moustafa, T; Silbert, D; Yang, M; Jaeschke, H; Stokman, G; Wells, R; Eller, K; Rosenkranz, AR; Eggertsen, G; Denk, H; Trauner, M
TUBULOINTERSTITIAL KIDNEY FIBROSIS AND CHRONIC RENAL FAILURE IN LONG-TERM COMMON BILE-DUCT-LIGATED MICE AS A RESULT OF COLLECTING DUCT INJURY: THE ROLE OF OSTEOPONTIN, FXR, AND CYP8B1
HEPATOLOGY. 2011; 54: 1250A-1251A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA.
Web of Science
Fickert, P; Thueringer, A; Moustafa, T; Yang, M; Jaeschke, H; Wells, RG; Stokman, G; Denk, H; Trauner, M
LONG-TERM COMMON BILE DUCT-LIGATION IN MICE INDUCES TUBULOINTERSTITIAL KIDNEY FIBROSIS AND CHRONIC RENAL FAILURE: ROLE OF BILE ACID NUCLEAR RECEPTOR FXR AND OSTEOPONTIN
J HEPATOL. 2011; 54: S244-S244.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(11)60602-8
Web of Science
FullText
FullText_MUG
Pollheimer, MJ; Fickert, P; Langner, C; Karlsen, TH; Trauner, M
ADHESION MOLECULE EXPRESSION PATTERN IN PRIMARY SCLEROSING CHOLANGITIS AND DISEASE CONTROLS
J HEPATOL. 2011; 54: S516-S516.
Doi: 10.1016/S0168-8278(11)61312-3
[Poster]
Web of Science
FullText
FullText_MUG
Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Halsegger, S; Adorini, L; Strazzabosco, M; Fickert, P; Trauner, M
THERAPEUTIC TARGETING OF NUCLEAR AND MEMBRANE BILE ACID RECEPTORS IN A MOUSE MODEL OF CHRONIC CHOLESTASIS
HEPATOLOGY. 2010; 52(4):724--The 61st Annual Meeting of the Americal Association fro teh Study of liver Diseases; OCT 29-NOV 02, 2010; Boston, MA, USA.
[Poster]
Web of Science
Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Halsegger, S; Volkl, R; Adorini, L; Fickert, P; Trauner, M
THERAPEUTIC EFFECTS OF FXR AND TGR5 ACTIVATION IN THE MDR2 (ABCB4)(-/-) MOUSE MODEL OF SCLEROSING CHOLANGITIS
J HEPATOL. 2010; 52: S354-S354.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)60914-2
[Oral Communication]
Web of Science
FullText
FullText_MUG
Fuchs, CD; Moustafa, T; Haemmerle, G; Halilbasic, E; Gumhold, J; Silbert, D; Fickert, P; Zechner, R; Trauner, M
ADIPOSE TRIGLYCERIDE LIPASE (ATGL) IS A NOVEL MODULATOR OF HEPATIC ER-STRESS
J HEPATOL. 2010; 52: S305-S305.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)60787-8
[Oral Communication]
Web of Science
FullText
FullText_MUG
Halilbasic, E; Claudel, T; Gumhold, J; Halsegger, S; Silbert, D; Fickert, P; Trauner, M
PREGNANCY RESOLVES LIVER FIBROSIS AND IMPROVES SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) -/- MICE VIA DIRECT ANTI-INFLAMMATORY EFFECTS OF SEX HORMONES
J HEPATOL. 2010; 52: S24-S24.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)60052-9
[Oral Communication]
Web of Science
FullText
FullText_MUG
Kniepeiss, D; Wagner, D; Gütl, M; Krause, R; Aigelsreiter, A; Iberer, F; Müller, H; Fickert, P; Tscheliessnigg, KH; Trauner, M; Stiegler, P
The liver takes it all.
Proceedings of the XXIII. Conference of the International Transplant Society2010; -XXIII. Conference of the International Transplant Society; Aug 15-19, 2010; Vancouver, Canada.
[Poster]
Krones, E; Halilbasic, E; Grisold, A; Krause, R; Trauner, M; Fickert, P; Zollner, G
Acute hepatitis species as a result of contamination of a food supplement with Cytotoxin-producing Bacillus species.
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A11.
[Poster]
Web of Science
Mader, JK; Bock, G; Wagner, M; Forrer, F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR
Recurrent hypoglycemia in adults - a diagnostic challenge (case report).
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A7-A7.-ÖGIM; Sep 29-Oct. 1; Salzburg, Austria.
[Poster]
Web of Science
Mader, JM; Bock, G; Wagner, M; Forrer,F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR;
Rezidivierende Hypoglykämie im Erwachsenenalter - eine diagnostische Herausforderung (Fallbericht).
Abstractband. 2010; -ÖGIM; 29.9-2.10.2010; Salzburg, Austria.
[Poster]
Moustafa, T; Fickert, P; Magnes, C; Frank, S; Kratky, D; Sinner, F; Gumhold, J; Silbert, D; Halsegger, S; Trauner M
METABOLIC REPROGRAMMING OF LIPID METABOLISM BY THE SIDE-CHAIN MODIFIED BILE ACID, 24-NORURSODEOXYCHOLIC ACID, RESTORES INFLAMMATION-DRIVEN LIVER INJURY AND ABERRANT PROLIFERATION IN ABCB4-/- MICE
J HEPATOL. 2010; 52: S20-S21.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)60049-9
[Oral Communication]
Web of Science
FullText
FullText_MUG
Pichler, M; Beham-Schmid, C; Lackner, K; Linkesch, W; Fickert, P; Emberger, W; Schmidt, H
Cholestatic hepatitis due to diffuse liver infiltration by Acute myelogenous leukemia with inv(16)(p13;q22): A case report and review of the literature
ONKOLOGIE. 2010; 33: 141-141.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oct 1 -5, 2010; Berlin, Germany.
[Poster]
Web of Science
Zollner, G; Thueringer, A; Lackner, C; Fickert, P; Trauner, M
ALTERATIONS OF CANALICULAR ATP-BINDING CASSETTE TRANSPORTERS IN PATIENTS WITH DRUG-INDUCED LIVER INJURY
J HEPATOL. 2010; 52: S449-S449.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)61163-4
[Poster]
Web of Science
FullText
FullText_MUG
Farzi, A; Fickert, P; Moustafa, T; Silbert, D; Trauner, M
mTOR signaling in chronic cholestatic liver injury.
Book of Abstracts and Conference Proceedings of the 1st annual meeting . 2009; -ÖGMBT (Austrian Association of Molecular Life Sciences and Biotechnology) Annual Meeting ; SEP 21-23, 2009; Innsbruck, AUSTRIA.
[Poster]
Jahnel, J; Claudel, T; Baghdasaryan, A; Langner, C; Fickert, P; Trauner, M; Hauer, AC; Silbert, A; Gumhold, J; Fuchsbichler, A
PHOSPHOLIPIDS AND COLITIS: IMPACT OF NUTRITIONAL AND BILIARY LACK OF PHOSPHOLIPIDS IN A COLITIS MOUSE MODEL
ACTA PAEDIAT. 2009; 98: 29-30.-50th Annual Meeting of the European Society for Paediatric Research ; October 9-12, 2009 ; Hamburg, Germany.
[Oral Communication]
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Lundasen, T; Gustafsson, U; Sahlin, S; Trauner, M
STIMULATION OF HEPATOBILIARY DETOXIFICATION AND TRANSPORT SYSTEMS IN HUMAN LIVER BY COMBINED TREATMENT WITH RIFAMPICIN AND URSODEOXYCHOLIC ACID
J HEPATOL. 2009; 50: 675-Vienna, Austria.
Doi: 10.1016/S0168-8278(09)60677-2
[Poster]
Web of Science
FullText
FullText_MUG
Marshall, H; Wagner, M; Zoller, G; Fickert, P; Gustafsson, U; Sahlin, S; Trauner, M
Combined treatment with rifamppicin and ursodeoxycholic acid in humans stimulates bile acid synthesis, detoxification and bilirubin elimination.
Gut2009; 58(SII):A49-A49.-GASTRO 2009 UEGW/WCOG; NOV 21-25,2009; London, GREAT BRITAIN.
[Oral Communication]
Moustafa, T; Fickert, P; Magnes, CH; Halilbasic, E; Fuchsbichler, A; Sinner, F; Fauler, G; Vesely, P; Frank, S; Kratky, D; Gumhold, J; Silbert, D; Denk, H; Guelli, CH; Trauner, M
24-norursodeoxycholic acid, a side-chain modified bile acid targets inflammation, oxidative stress and lipid metabolism in chronic liver injury.
keine2009; -ZMF & Doctoral Day; Nov, 2009; Graz, AUSTRIA.
[Poster]
Baghdasaryan, A; Claudel, T; Kosters, A; Gumhold, J; Silbert, D; Fuchsbichler, A; Leski, K; Fickert, P; Karpen, SJ; Trauner, M
Curcumin Feeding Ameliorates Cholangiopathy in Mdr2 (Abcb4) Knockout Mice
AASLD monothematic conference, Pathobiology of Biliary Epithelia and Cholangiocarcinoma . 2008; -AASLD monothematic conference, Pathobiology of Biliary Epithelia and Cholangiocarcinoma ; JUNE 6-8, 2008 ; Atlanta, GA, USA.
[Poster]
Baghdasaryan, A; Kosters, A; Claudel, T; Fuchsbichler, A; Gumhold, J; Silbert, D; Leski, K; Fickert, P; Karpen, SJ; Trauner, M
Curcumin improves liver injury and biliary fibrosis in MDR2 (ABCB4) knockout mice by inducing anti-oxidative response, but not via modification of bile acid transport/metabolism
J HEPATOL. 2008; 48: S171-S171.-EASL Annual Meeting; April 2008; Milan Italy.
Doi: 10.1016/S0168-8278(08)60450-X
[Poster]
Web of Science
FullText
FullText_MUG
Baghdasaryan, A; Kosters, A; Claudel, T; Fuchsbichler, A; Gumhold, J; Silbert, D; Leski, K; Fickert, P; Karpen, SJ; Trauner, M
Curcumin improves liver injury in Mdr2 (Abcb4) knockout mice by inducing anti-oxidative response, but not via modification of bile acid transport/metabolism
XX International Bile Acid Meeting, Bile Acid Biology and Therapeutic Actions . 2008; -XX International Bile Acid Meeting, Bile Acid Biology and Therapeutic Actions ; JUNE 13-14, 2008; Amsterdam, the Netherlands.
[Oral Communication]
Baghdasaryan, A; Kosters, A; Claudel, T; Fuchsbichler, A; Gumhold, J; Silbert, D; Leski, K; Fickert, P; Karpen, SJ; Trauner M.
Curcumin improves liver injury in Mdr2 (Abcb4) knockout mice by inducing anti-oxidative response, but not via modification of bile acid transport/metabolism
XX International Bile Acid Meeting, Bile Acid Biology and Therapeutic Actions. 2008; -XX International Bile Acid Meeting, Bile Acid Biology and Therapeutic Actions.; June 13-14, 2008; Amsterdam, the Netherlands..
[Poster]
Fickert, P; Moustafa, T; Fuchsbichler, A; Claudel, T; Kratky, D; Denk, H; Trauner, M
Differential effects of norUDCA and UDCA in the treatment of fatty liver disease and atherosclerosis.
keine2008; -ZMF Day; NOV, 2008; Graz, AUSTRIA.
[Poster]
Fickert, P; Moustafa, T; Fuchsbichler, A; Claudel, T; Halilbasic, E; Zatloukal, K; Denk, H; Trauner, M
Differential effects of nor UDCA and UDCA in the treatment of fatty liver and arteriosclerosis in western chow-fed ApoE knock out mice
J HEPATOL. 2008; 48: S42-S42.-Annual Meeting, EASL; April 2008; Milann, Italy.
Doi: 10.1016/S0168-8278(08)60100-2
[Oral Communication]
Web of Science
FullText
FullText_MUG
Moustafa, T; Fickert, P; Fuchsbichler, A; Fauler, G; Streith, I; Vesely, P; Silbert, D; Gumhold, J; Denk, H; Trauner, M
Side-chain modification of Ursodeoxycholic acid alters cellular hyper-proliferation and lipid homeostasis in a mouse model of chronic cholestatic liver injury.
keine2008; -ZMF Day; NOV, 2008; Graz, AUSTRIA.
[Oral Communication]
Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Halilbasic, E; Trauner, MH
LOSS OF FXR ATTENUATES SCLEROSING CHOLANGITIS AND BILIARY FIBROSIS IN MDR2(-/-) AND FXR(-/-) DOUBLE KNOCKOUT MICE
HEPATOLOGY. 2008; 48(4):777--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA.
[Poster]
Web of Science
Moustafa, T; Halilbasic, E; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Denk, H; Trauner, M
Side chain modified bile acids modulate endoplasmic reticulum stress in Mdr2(-/-) mice in vivo and bile duct epithelial cells in vitro
J HEPATOL. 2008; 48: S54-S55.-EASL Annula Meeting; April 2008; Milan Italy.
Doi: 10.1016/S0168-8278(08)60127-0
[Oral Communication]
Web of Science
FullText
FullText_MUG
Sombetzki, M; Fickert, P; Loebermann, M; Holtfreter, M; Fuchsbichler, A; Gumhold, J; Silbert, D; Langner, C; Reisinger, EC; Trauner, M
24-nor-ursodeoxycholic acid as novel therapeutic strategy for inflammation-induced liver fibrosis in a murine model of schistosoma mansoni infection
J HEPATOL. 2008; 48: S21-S22.-Annual Meeting, EASL; April 2008; Mailand, Italien.
Doi: 10.1016/S0168-8278(08)60052-5
[Oral Communication]
Web of Science
FullText
FullText_MUG
Halilbasic, E; Fickert, P; Fuchbichler, A; Langner, C; Gumhold, J; Silbert, D; Maitra, U; Zatloukal, K; Denk, H; Trauner, M
Taurine-conjugation critically determines the therapeutic effectiveness of 24-nor-ursodeoxycholic acid (norUDCA) in the treatment of sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
J HEPATOL. 2007; 46: S51-S51.-EASL; April 11-15, 2007;
Doi: 10.1016/S0168-8278(07)61714-0
[Oral Communication]
Web of Science
FullText
FullText_MUG
Halilbasic, E; Fickert, P; Fuchsbichler, A; Moustafa, T; Stoeger, U; Ueno, Y; Denk, H; Trauner, M
TNF alpha and LPS but not bile acids play a key role in the induction of reactive phenotype in bile duct epithelial cells in vitro
J HEPATOL. 2007; 46: S121-S121.-EASL; April 11-15, 2007; Barcelona/Spain.
Doi: 10.1016/S0168-8278(07)61905-9
[Poster]
Web of Science
FullText
FullText_MUG
Jahnel, J; Wagner, M; Langner, C; Hoegenauer, C; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M
Impact of colitis on bile secretion and hepatobiliary transporter expression in mice possible implications for pathogenesis of sclerosing cholangitis
J HEPATOL. 2007; 46: S122-S122.
Doi: 10.1016/S0168-8278(07)61907-2
[Poster]
Web of Science
FullText
FullText_MUG
Maitz, S; Wimmer, R; Rust, C; Denk, H; Invernizzi, P; Ferdinandusse, S; Wanders, RJ; Fuchsbichler, A; Fickert, P; Trauner, M; Hofmann, AF; Beuers, U
Taurine conjugation is essential for anticholestatic action of norursodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver
HEPATOLOGY. 2007; 46(4):338A-339A.-AASLD; NOV 2-6, 2007; Boston, USA.
[Poster]
Web of Science
Moustafa, T; Fickert, P; Vesely, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Guelly, C; Trauner, M
Retention of toxic bile acids activate the mTOR, p70S6k/rps6 signaling pathway in mouse models of cholestatic liver injury
J HEPATOL. 2007; 46: S23-S23.
Doi: 10.1016/S0168-8278(07)61646-8
[Oral Communication]
Web of Science
FullText
FullText_MUG
Wagner, M; Moustafa, T; Fickert, P; Zollner, G; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Absence of FXR protects mice from bile-infarcts in biliary obstruction by reduction of bile acid-independent bile flow: Implications for targeting FXR in treatment of cholestasis?
J HEPATOL. 2007; 46: S5-S5.-42th Annual Meeting, European Association for the Study of the Liver; April, 11-15, 2007; Barcelona, Spain.
Doi: 10.1016/S0168-8278(07)61603-1
[Oral Communication]
Web of Science
FullText
FullText_MUG
Zollner, G; Caligiuri, A; Fickert, P; Wagner, M; Silbert, D; Pinzani, M; Trauner, M
Expression of bile acid transport and detoxification systems and their regulatory nuclear receptors in human hepatic stellate cells
J HEPATOL. 2007; 46: S135-S135.-42th Annual Meeting, European Association for the Study of the Liver ; April 11-15, 2007; Barcelona, Spain.
Doi: 10.1016/S0168-8278(07)61944-8
[Poster]
Web of Science
FullText
FullText_MUG
Bernhardt, GA; Zollner, G; Kornprat, P; Cerwenka, H; Bacher, H; Mischinger, HJ; Fickert, P; Trauner, M
Influence of Pringle maneuver in liver resections on hepatobiliary transporter expression.
Hepato-Gastroenterology. Hepato-Gastroenterol 2006; 53(S1):178-179.-World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists; MAY 26, 2006; Madrid.
[Poster]
Moustafa, T; Fickert, P; Fuchsbichler, A; Vesely, P; Silbert, D; Gumhold, J; Denk, H; Guelly, CH; Trauner, M
he side-chain shortened bile acid 24-norUDCA reverses biliary fibrosis and alters cellular hyperproliferation in a mouse model of chronic cholestatic liver injury.
keine2006; -ZMF Day; NOV, 2006; Graz, AUSTRIA.
[Oral Communication]
Moustafa, T; Fickert, P; Guelly, C; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M
Transcriptional profiling of Mdr2 knockout (Mdr2-/-) mice treated with nor-UDCA reveals global anti-inflammatory and anti-fibrotic effects
J HEPATOL. 2006; 44: S42-S42.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80095-4
[Poster]
Web of Science
FullText
FullText_MUG
Moustafa, T; Fickert, P; Guelly, C; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M
24-nor-ursodeoxycholic acid abolishes enhanced cellular proliferation in Mdr2 (abcb4) knockout mice by modulation of mTOR, p70s6k and rps6 signaling
HEPATOLOGY. 44(4):602A-603A.
[Poster]
Web of Science
Moustafa, T; Fickert, P; Kratky, D; Prokesch, A; Trajanoski, Z; Trauner, M
The nuclear bile acid receptor FXR is required to balance intra-hepatic lipid synthesis, storage and utilization in a mouse model of cholestatic liver injury.
keine2006; -Keystone Symposium; JAN, 2006; Colorado, USA.
[Poster]
Moustafa, T; Fickert, P; Prokesch, A; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Denk, H; Trajanoski, Z; Trauner, M
Common bile-duct-ligation of FXR knockout mice results in severe hepatic steatosis due to enhancement in lipogenic gene expression
J HEPATOL. 44: S28-S28.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80063-2
[Poster]
Web of Science
FullText
FullText_MUG
Scheidl, S; Hesse, C; Fickert, P; Müller, H; Klepetko, W; Olschewski, H
Pitfalls with echocardiography after pulmonary thrombendarterectomy for CTEPH.
ÖGP; Graz. 2006.
[Poster]
Stoger, U; Fickert, P; Fuchsbichler, A; Moustafa, T; Gumhold, J; Silbert, D; Zatlouka, K; Denk, H; Trauner, M
3.5-diethoxycarbonyl-1.4-dihydrocollidine (DDC) feeding induces cholestasis, chronic inflammatory bile duct damage and biliary fibrosis in mice
J HEPATOL. 44: S123-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80321-1
[Poster]
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Trauner, M
24-nor-ursodeoxycholic acid ameliorates sclerosing cholangitis in Mdr2 knockout mice.
4th Central European Gastroenterology Meeting; Juni 29 - Juli 2; Visegrad, Ungarn. 2006.
[Oral Communication]
Wagner, M; Halilbasic, E; Marschall, HU; Zollner, G; Fickert, P; Langner, C; Zatloukal, K; Denk, H; Trauner, M
CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8; Graz. 2006.
[Oral Communication]
Zollner, G; Fuchsbichler, A; Fickert, P; Denk, H; Trauner, M
Alterations of hepatic bilirubin and phospholipid export pumps MRP2 and MDR3 in patients with drug-induced liver injury
HEPATOLOGY. 44(4):381A-381A.
[Poster]
Web of Science
Zollner, G; Wagner, M; Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Helmut, D; Marschall, HU; Trauner, M
Role of nuclear bile acid receptor FXR in regulation of bile acid detoxification and organic solute transporter (OST-alpha/beta) expression in bile acid-fed mice
J HEPATOL. 44: S124-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80322-3
[Poster]
Web of Science
FullText
FullText_MUG
Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Krause, R; Zatloukal, K; Marschall, HU; Jaeschke, H; Denk, H; Trauner, M
Lithocholic acid feeding induces biliary obstruction and destructive cholangitis in mice
J HEPATOL. 2005; 42: 113-113.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Fickert, P; Wagner, M; Marshall, HU; Fuchsbichler, A; Zollner, G; Zatloukal, K; Liu, J; Waalkes, MP; Cover, C; Denk, H; Hofmann, AF; Jaeschke, H; Trauner, M
24-norursodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
HEPATOLOGY. 2005; 42: -56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science
Geier, A; Zollner, G; Dietrich, CG; Wagner, M; Fickert, P; Denk, H; van Rooijen, N; Matern, S; Gartung, C; Trauner, M
Cytokine-independent repression of rodent Ntcp in obstructive cholestasis
J HEPATOL. 2005; 42: 114-114.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Janig, E; Fuchsbichler, A; Fickert, P; Trauner, M; Denk, H; Zatloukal, K
Clusterin: A novel stress marker in biliary disease models
HEPATOLOGY. 2005; 42 (4): 413-414.-56th Annual Meeting of the American Association for the Study of Liver Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Gustafsson, U; Sahlin, S; Einarsson, C; Trauner, M
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in human liver
GASTROENTEROLOGY. 2005; 128: A755-A755.
Web of Science
Marschall, HU; Wagnr, M; Bodin, K; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Sjovall, J; Trauner, M
Fxr -/- mice adapt to obstructive cholestasis by enhanced phase I detoxification and renal elimination of bile acids
J HEPATOL. 2005; 42: 114-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, J; Zatloukal, K; Jaeschke, H; Deck, H; Trauner, M
Role of inflammation for hepatobiliary transporter expression in ICAM-/- and lpr mice after common bile duct ligation
GASTROENTEROLOGY. 2005; 128: A89-A89.
Web of Science
Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, JS; Zatloukal, K; Denk, H; Jaeschke, H; Trauner, M
Alterations of hepatobiliary transporter expression in response to common bile duct ligation in mice are independent of ICAM-1 and FAS-receptor expression
J HEPATOL. 2005; 42: 115-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M
Expression of key bile acid detoxification enzymes and the alternative bile acid export pump MRP4 in primary biliary cirrhosis
J HEPATOL. 2005; 42: 240-240.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M
Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis
GASTROENTEROLOGY. 2005; 128: A691-A691.
Web of Science
Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Biliary leakage of fluorescent bile acids in MDR2 knockout mice: Evidence for a critical role of bile duct leakage in the pathogenesis of sclerosing cholangitis
J HEPATOL. 2004; 40: 91-91.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90295-4
Web of Science
FullText
FullText_MUG
Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Bile acids regurgitation from leaky bile ducts causes sclerosing cholangitis in Mdr2 knockout mice
GASTROENTEROLOGY. 2004; 126: A663-A663.
Web of Science
Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Marschall, HU; Zartloukal, K; Denk, H; Zsengeller, Z; Szabo, C
Oncosis represents the main type of cell death in mouse models of cholestasis: evidence for a critical role of poly(ADP-ribose) polymerase (PARP) activation in bile acid-induced hepatocytes death
FASEB J. 2004; 18: A558-A558.-Experimental Biology 2004 Meeting; APR 17-21, 2004; Washington, DC.
Web of Science
Knight, T; Fickert, P; Fuchsbichler, A; Trauner, M; Jaeschke, H
Pathophysiological role of poly(adenosine 5'-diphosphate-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
HEPATOLOGY. 2004; 40: 650A-650A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M
Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
GASTROENTEROLOGY. 2004; 126: A746-A746.
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumholdt, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M
Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
J HEPATOL. 2004; 40: 93-93.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90303-0
Web of Science
FullText
FullText_MUG
Rust, C; Bauchmuller, K; Fickert, P; Fuchsbichler, A; Beuers, U
Phosphatidylinositol 3-kinase acid - Dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers.
HEPATOLOGY 2004 40: 568A-568A.
Web of Science
Wagner, M; Fickert, P; Marschall, HU; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M
Alternative exretory routes for accumulating bile acids via adaptive renal ABC transporter expression in common bile duct-ligated (CBDL) mice
GASTROENTEROLOGY. 2004; 126: A129-A130.
Web of Science
Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Gu, GL; Marschall, HU; Denk, H; Trauner, M
Role of adaptive hepatobiliary transporter expression and regulation of bile acid synthetic enzymes in MDR2-/- mice: A model for chronic cholestatic liver disease due to sclerosing cholangitis
J HEPATOL. 2004; 40: 163-163.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90557-0
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Adaptive renal ABC transporter expression in common bile duct-ligated mice
J HEPATOL. 2004; 40: 26-26.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90073-6
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Hepatic and renal ABC transporter expression in mice depends on gender and changes in pregnancy
GASTROENTEROLOGY. 2004; 126: A130-A130.
Web of Science
Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Gender and pregnancy affect hepatic and renal ABC transporter expression in mice
J HEPATOL. 2004; 40: 94-94.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90307-8
Web of Science
FullText
FullText_MUG
Wagner, M; Halilbasic, E; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Denk, H; Trauner, M
Nuclear receptor (PXR, CAR) agonists induce adaptive hepatic transporter and enzyme expression in mouse liver
J HEPATOL. 2004; 40: 25-25.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90069-4
Web of Science
FullText
FullText_MUG
Wagner, M; Halilbasic, E; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Xenobiotic nuclear receptor (PXR, CAR) agonists coordinately stimulate a spectrum of detoxification enzymes and transport systems involved in the adaptive response to cholestasis in vivo.
HEPATOLOGY. 2004; 40: 489A-489A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science
Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel abc transporters, in mice
J HEPATOL. 2004; 40: 25-25.
Doi: 10.1016/S0168-8278(04)90070-0
Web of Science
FullText
FullText_MUG
Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Cholic acid (CA) and ursodeoxycholic acid (UDCA) exert different effects on hepatic and renal expression of Mrp4 and Mrp6, two novel ABC transporters
GASTROENTEROLOGY. 2004; 126: A16-A16.
Web of Science
Zollner, G; Wagner, M; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Guo, GL; Marschall, HU; Denk, H; Trauner, M
Mdr2(-/-) mice with sclerosing cholangitis: A model of chronic cholestasis to study the role of the adaptive response of hepatobiliary transport systems and bile acid synthetic enzymes
GASTROENTEROLOGY. 2004; 126: A751-A751.
Web of Science
Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Zenz, R; Zsengeller, Z; Szabo, C; Denk, H
Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cholestatic liver injury.
HEPATOLOGY 2003 38: 576A-576A.
Web of Science
Trauner, M; Fickert, P; Zollner, G; Zatloukal, K; Denk, H
Acquired alterations of hepatobiliary transport systems in human cholestatic liver diseases: potential targets of pharmacotherapy
In: Paumgartner, G; Keppler, D; Leuschner, U; Stiehl, A editor(s).FALK SYMPOSIUM; BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY; MAY 30-JUN 01, 2002; FREIBURG, GERMANY. DORDRECHT: KLUWER ACADEMIC PUBL; 2003. p.163-177.
Wagner, M; Fickert, P; Fuchsbichler, A; Silbert, D; Gumhold, J; Zollner, G; Zatloukal, K; Marschall, HU; Schuetz, JD; Gonzalez, FJ; Denk, H; Trauner, M
Hepatic and renal ABC transporter expression as critical determinants of ursodeoxycholic acid-induced bile infarcts in bile duct-ligated mice.
HEPATOLOGY 2003 38: 688A-689A.
Web of Science
Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Marschall, HU; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M
The role of the bile acid receptor FXR in determining ATP-binding cassette (ABC) transporter expression and liver injury in common bile duct ligated (CBDL) mice
J HEPATOL 2003 38: 190-190.
Doi: 10.1016/S0168-8278(03)80031-4
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Tsybrovskyy, O; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Role of nuclear bile acid receptor, FXR, in determining ATP-binding cassette (ABC) transporter expression and cholestatic liver injury in common bile duct-ligated mice
GASTROENTEROLOGY 2003 124: A697-A698.
Doi: 10.1016/S0016-5085(03)83527-8
Web of Science
FullText
FullText_MUG
Zatloukal, K; Stumptner, C; Fuchsbichler, A; Fickert, P; Trauner, M; Denk, H
The role of keratin in steatohepatitis.
HEPATOLOGY 2003 38: 501A-501A.
Web of Science
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Guo, G; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M
Role of nuclear bile salt receptors Fxr and Pxr in mediating adaptive hepatobiliary transporter response to cholic acid (CA) in mouse liver
GASTROENTEROLOGY 2003 124: A59-A59.
Doi: 10.1016/S0016-5085(03)80292-5
Web of Science
FullText
FullText_MUG
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M
Regulation of the Na+/taurocholate cotransporter Ntcp via short heterodimer partner (SHP)-dependent or SHP-independent mechanims depends on the type of cholestatic injury
GASTROENTEROLOGY 2003 124: A730-A730.
Doi: 10.1016/S0016-5085(03)83688-0
Web of Science
FullText
FullText_MUG
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M
Role of short heterodimer partner (SHP) -dependent and -independent pathways for regulation of Na+/taurocholate cotransporter (NTCP) expression in cholestatic mouse models.
J HEPATOL. 2003; 38(2):9-10.-38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; MAR 29-APR 01, 2003; ISTANBUL, TURKEY.
Doi: 10.1016/S0168-8278(03)80442-7
Web of Science
PubMed
FullText
FullText_MUG
Zollner, G; Fickert, P; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Zatloukal, K; Denk, H; Trauner, M
Induction of intestinal multidrug resistance-associated proteins 2 and 3 (Mrp2, Mrp3) by cholic acid (CA) and ursodeoxycholic acid (UDCA) in mice.
HEPATOLOGY 2003 38: 689A-689A.
Web of Science
Fickert, P; Trauner, M; Fuchsbichler, A; Stumptner, C; Neuberger, J; Zatloukal, K; Denk, H
Abnormal expression and phosphorylation of cytokeratins in primary biliary cirrhosis (PBC).
J HEPATOL. 2002; 36(S1):141-141.
Doi: 10.1016/S0168-8278(02)80506-2
Web of Science
PubMed
FullText
FullText_MUG
Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Arbeiter, S; Gonzalez, F; Denk, H; Trauner, M
Adaptive hepatic and renal transporter regulation in cholic acid (CA)-fed mice: Role of nuclear bile acid receptor (FXR).
HEPATOLOGY 2002 36: 454A-454A.
Web of Science
Zollner, G; Fickert, P; Arbeiter, S; Silbert, D; Fuchsbichler, A; Gonzalez, F; Zatloukal, K; Denk, H; Trauner, M
Ursodeoxycholic acid (UDCA) feeding induces adaptive hepatic and renal ABC-transporter expression in mice.
HEPATOLOGY 2002 36: 454A-454A.
Web of Science
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Stumptner, C; Neuberger, J; Zatloukal, K; Denk, H; Trauner, M
Alterations of hepatobiliary transporter expression in primary biliary cirrhosis (PBC)
J HEPATOL 2002 36: 28-29.
Doi: 10.1016/S0168-8278(02)80086-1
Web of Science
FullText
FullText_MUG
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Messenger RNA expression of nuclear, orphan receptors and hepatocyte nuclear factor 1 alpha (HNF-1 alpha) in inflammation-associated cholestasis (IC) and primary biliary cirrhosis
HEPATOLOGY 2002 36: 454A-454A.
Web of Science
Fickert, P; Fuchsbichler, A; Zollner, G; Stumptner, C; Weiglein, A; Zatloukal, K; Denk, H; Trauner, M
Mdr2-p-glycoprotein-deficient (Mdr2-/-) mouse - A new model for primary sclerosing cholangitis (PSC)?
HEPATOLOGY 2001 34: 509A-509A.
Web of Science
Fickert, P; Zollner, G; Fuchsbichler, A; Stumptner, C; Lammert, F; Zaltloukal, K; Denk, H; Trauner, M
Ursodeoxycholic acid (UDCA) feeding aggravates liver injury in bile duct-ligated and Mdr2 kockout mice
J HEPATOL 2001 34: 182-182.
Web of Science
Fickert, P; Zollner, G; Fuchsbichler, A; Stumptner, C; Lammert, F; Zatloukal, K; Denk, H; Trauner, M
Ursodeoxycholic acid feeding aggravates liver injury in bile duct-ligated mice
GASTROENTEROLOGY 2001 120: A1-A1.
Web of Science
Trauner, M; Fickert, P; Zollner, G; Stauber, RE; Krejs, GJ
Molecular basis of bile formation and cholestasis
In: Acalovschi, M; Paumgartner, G editor(s).FALK SYMPOSIUM; HEPATOBILIARY DISEASES: CHOLESTASIS AND GALLSTONES; JUN 09-10, 2000; CLUJ-NAPOCA, ROMANIA. DORDRECHT: KLUWER ACADEMIC PUBL; 2001. p.3-20.
Zollner, G; Fickert, P; Fuchsbichler, A; Stumptner, C; Denk, H; Zatloukal, K; Ferenci, P; Trauner, M
Expression of multidrug resistance P-glycoproteins (MDRs) and multidrug resistance-associated proteins (MRPs) in Wilson disease (WD)
J HEPATOL 2001 34: 188-188.
Web of Science
Zollner, G; Fickert, P; Fuchsbichler, A; Stumptner, C; Denk, H; Zatloukal, K; Trauner, M
Multidrug resistance P-glycoproteins (MDR) and multidrug resistance-associated proteins (MRP) are not overexpressed in human hepatocellular carcinomas (HCC).
J HEPATOL 2001 34: 189-189.
Web of Science
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Stumptner, C; Ott, P; Zatloukal, K; Denk, H; Trauner, M
Expression of multidrug resistance p-glycoproteins (MDR), multidrug resistance-associated proteins (MRP) and bile acid transporters in human hepatocellular carcinomas (HCC).
HEPATOLOGY 2001 34: 665A-665A.
Web of Science
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M; Franzens, K
Induction of the transcriptional repressor short heterodimer partner 1 precedes down-regulation of the Na+/taurocholate cotransporter in bile duct-ligated mice.
HEPATOLOGY 2001 34: 469A-469A.
Web of Science
Auner,HW; Beham-Schmid,C; Lindner,G; Fickert,P; Linkesch,W; Sill,H;
Successfull non-surgical treatment of primary mucosa associated lymphoid tissue(MALT) lymphoma of colon presenting with multiple polypoid lesions.
Acta Med Aust. 2000; 27: 18-18.- ; ; .
[Keynote lecture]
Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H
Toxic bile acids induce cytokeratin 8/18 overexpression and hyperphosphorylation in mouse liver.
GASTROENTEROLOGY 2000 118: 3726-3726.
Doi: 10.1016/S0016-5085(00)86223-X
Web of Science
FullText
FullText_MUG
Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H
Cytokeratin 8/18 overexpression and hyperphosphorylation induced by toxic bile acids in mouse liver
J HEPATOL 2000 32: 76-76.
Doi: 10.1016/S0168-8278(00)80623-6
Web of Science
FullText
FullText_MUG
Fickert, P; Zenz, R; Zoliner, G; Pojer, C; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Role of bile acid hydrophobicity in regulation of hepatocellular transporter expression in mice
J HEPATOL. 2000; 32(1 Su):39-39.
Doi: 10.1016/S0168-8278(00)80479-1
Web of Science
FullText
FullText_MUG
Fickert, P; Zenz, R; Zollner, G; Pojer, C; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Regulation of hepatocellular transporter expression depends on bile acid hydrophobicity in mice.
GASTROENTEROLOGY 2000 118: 168-168.
Doi: 10.1016/S0016-5085(00)85876-X
Web of Science
FullText
FullText_MUG
Stauber, RE; Hegenbarth, KS; Maurer, U; Kroisel, PM; Fickert, P; Trauner, M
No evidence for teratogenic effects of ribavirin: Report of two cases.
HEPATOLOGY 2000 32: 1639-1639.
Web of Science
Wenzl, HH; Hinterleitner, TA; Fickert, P; Aichbichler, BW; Metzler, O; Derler, AM; Petritsch, W
Low efficacy of long-term treatment with mycophenolate mofetil in patients with Crohn's disease.
GASTROENTEROLOGY 2000 118: 4214-4214.
Doi: 10.1016/S0016-5085(00)85302-0
Web of Science
FullText
FullText_MUG
Auner,H; Beham-Schmd,Ch; Lindner,G; Fickert,P; Linkesch,W; Sill,H;
Successful non-surgical treatment of primary colorectal MALT-lymphomas. An organ-preserving therapeutic concept.
Onkologie1999; 22: 89-89.- ; ; .
[Poster]
Fickert, P; Trauner, M; Fuchsbichler, A; Kenner, L; Zatloukal, K; Denk, H
Role of Kupffer cells in hepatocellular cytokeratin 8/18 expression in lipopoly-saccharide or DDC-induced hepatic injury.
HEPATOLOGY 1999 30: 552A-552A.
Web of Science
Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H
Cholestasis and bile acid feeding induce cytokeratin 8/18 expression and mallory body formation in mice.
HEPATOLOGY 1999 30: 464A-464A.
Web of Science
Stumptner, C; Zatloukal, K; Fickert, P; Denk, H
P62/A170 - A novel component of Mallory Bodies associated with alcoholic hepatitis.
HEPATOLOGY 1999 30: 551A-551A.
Web of Science
Stumptner, C; Zatloukal, K; Fickert, P; Denk, H
p62/A170 - A novel component of mallory bodies associated with alcoholic hepatitis.
HEPATOLOGY 1999 30: 412A-412A.
Web of Science
Trauner, M; Fickert, F; Zenz, R; Pojer, C; Fuchsbichler, A; Zollner, G; Denk, H; Zatloukal, K
Role of Kupffer cells in regulation of multidrug resistance (mdr) P-glycoprotein expression in intrahepatic and obstructive cholestasis.
HEPATOLOGY 1999 30: 463A-463A.
Web of Science
Trauner, M; Zenz, R; Fickert, P; Kenner, L; Stauber, RE; Denk, H; Zatloukal, K
Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis.
HEPATOLOGY 1999 30: 467A-467A.
Web of Science
Kenner, L; Stumptner, C; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K
Tau overexpression in human alcoholic liver disease.
HEPATOLOGY 1998 28: 512A-512A.
Web of Science
Kenner, L; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K
Overexpression of keratin-8 and -18 RNA associated with mallory body formation in patients with alcoholic hepatitis.
HEPATOLOGY 1998 28: 303A-303A.
Web of Science
Stauber, RE; Trauner, M; Fickert, P
Soreness of mucosal membranes in patients receiving interferon-alpha plus ribavirin for treatment of chronic hepatitis C.
HEPATOLOGY 1998 28: 704A-704A.
Web of Science
Eferl, R; Kenner, L; Fickert, P; Stauber, R; Denk, H; Zatloukal, K
Validation of quantitative reverse transcription polymerase chain reaction for analysis of gene expression in liver biopsies.
HEPATOLOGY 1997 26: 1496-1496.
Web of Science
Fickert, P; Hinterleitner, TA; Aichbichler, B; Wenzl, HH; Petritsch, W
Mycophenolate mofetil in patients with Crohn's disease
GASTROENTEROLOGY 1997 112: A972-A972.
Web of Science
Hinterleitner, TA; Fickert, P; Pamperl, I; Lindschinger, M; Anderhuber, W; Stammberger, H; Petritsch, W
Percutaneous endoscopic gastrostomy prevents aspiration but has no effect on quality of life and physical activity in patients with radiation therapy for neck cancer
GASTROENTEROLOGY 1997 112: A879-A879.
Web of Science
Kessler, HH; Pierer, K; Fickert, P; Stauber, RE
Virological and biochemical response to combined interferon-alpha plus ribavirin therapy in patients with chronic hepatitis C.
GASTROENTEROLOGY 1997 112: A1300-A1300.
Web of Science
Fickert, P; Ramschak, H; Kenner, L; Hoefler, G; Hinterleitner, TA; Petritsch, W; Klimpfinger, M; Krejs, GJ; Stauber, RE
Acute Budd Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation.
HEPATOLOGY 1996 24: 1534-1534.
Web of Science
Heinemann, A; Fickert, P; Stauber, RE
The effect of vasopressin analogues on the in vitro vascular reactivity in portal hypertension
HEPATOLOGY 1996 24: 1585-1585.
Web of Science
HITNERLEITNER, TA; EHERER, AJ; FICKERT, P; PETRITSCH, W; BEUBLER, E; FRIEDLAND, T; KREJS, GJ
SACCHAROMYCES-BOULARDII HAS NO EFFECT ON CHOLERA TOXIN-INDUCED WATER AND ELECTROLYTE SECRETION IN THE HUMAN JEJUNUM
GASTROENTEROLOGY 1995 108: A290-A290.
Web of Science
STAUBER, RE; JAUK, B; FICKERT, P; HÄUSLER, MCH
CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) IS ELEVATED IN PREMENOPAUSAL AND IN PREGNANT-WOMEN
HEPATOLOGY 1995 22: 1550-1550.
Web of Science